EA025884B1 - ПИПЕРАЗИНО[1,2-a]ИНДОЛ-1-ОНЫ И [1,4]ДИАЗЕПИНО[1,2-a]ИНДОЛ-1-ОН - Google Patents
ПИПЕРАЗИНО[1,2-a]ИНДОЛ-1-ОНЫ И [1,4]ДИАЗЕПИНО[1,2-a]ИНДОЛ-1-ОН Download PDFInfo
- Publication number
- EA025884B1 EA025884B1 EA201590125A EA201590125A EA025884B1 EA 025884 B1 EA025884 B1 EA 025884B1 EA 201590125 A EA201590125 A EA 201590125A EA 201590125 A EA201590125 A EA 201590125A EA 025884 B1 EA025884 B1 EA 025884B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pyrazino
- methyl
- dihydro
- indol
- oxo
- Prior art date
Links
- CVCSXBCKBNWYAB-UHFFFAOYSA-N [1,4]diazepino[1,2-a]indol-1-one Chemical compound O=C1N=CC=CN2C3=CC=CC=C3C=C12 CVCSXBCKBNWYAB-UHFFFAOYSA-N 0.000 title description 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 398
- -1 benzo[1,3]dioxolyl Chemical group 0.000 claims abstract description 148
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 118
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 63
- 150000002367 halogens Chemical class 0.000 claims abstract description 63
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 41
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 40
- 239000000203 mixture Substances 0.000 claims abstract description 39
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 33
- 239000001257 hydrogen Substances 0.000 claims abstract description 33
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 32
- 150000003839 salts Chemical class 0.000 claims abstract description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000002253 acid Substances 0.000 claims abstract description 20
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 claims abstract description 14
- 208000010877 cognitive disease Diseases 0.000 claims abstract description 13
- 239000003814 drug Substances 0.000 claims abstract description 13
- 125000001424 substituent group Chemical group 0.000 claims abstract description 12
- 229940079593 drug Drugs 0.000 claims abstract description 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 11
- 230000003287 optical effect Effects 0.000 claims abstract description 11
- 230000032683 aging Effects 0.000 claims abstract description 10
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims abstract description 10
- 238000011282 treatment Methods 0.000 claims abstract description 10
- 208000024827 Alzheimer disease Diseases 0.000 claims abstract description 9
- 208000019901 Anxiety disease Diseases 0.000 claims abstract description 9
- 230000037326 chronic stress Effects 0.000 claims abstract description 9
- 108010078286 Ataxins Proteins 0.000 claims abstract description 8
- 102000014461 Ataxins Human genes 0.000 claims abstract description 8
- 208000020925 Bipolar disease Diseases 0.000 claims abstract description 8
- 206010008025 Cerebellar ataxia Diseases 0.000 claims abstract description 8
- 206010011878 Deafness Diseases 0.000 claims abstract description 8
- 206010012289 Dementia Diseases 0.000 claims abstract description 8
- 201000010374 Down Syndrome Diseases 0.000 claims abstract description 8
- 208000023105 Huntington disease Diseases 0.000 claims abstract description 8
- 201000007737 Retinal degeneration Diseases 0.000 claims abstract description 8
- 208000009415 Spinocerebellar Ataxias Diseases 0.000 claims abstract description 8
- 208000009205 Tinnitus Diseases 0.000 claims abstract description 8
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims abstract description 8
- 201000004562 autosomal dominant cerebellar ataxia Diseases 0.000 claims abstract description 8
- 206010015037 epilepsy Diseases 0.000 claims abstract description 8
- 230000010370 hearing loss Effects 0.000 claims abstract description 8
- 231100000888 hearing loss Toxicity 0.000 claims abstract description 8
- 208000016354 hearing loss disease Diseases 0.000 claims abstract description 8
- 208000024714 major depressive disease Diseases 0.000 claims abstract description 8
- 229960001252 methamphetamine Drugs 0.000 claims abstract description 8
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 claims abstract description 8
- 208000027061 mild cognitive impairment Diseases 0.000 claims abstract description 8
- 201000006417 multiple sclerosis Diseases 0.000 claims abstract description 8
- 208000030459 obsessive-compulsive personality disease Diseases 0.000 claims abstract description 8
- 229940127240 opiate Drugs 0.000 claims abstract description 8
- 208000019906 panic disease Diseases 0.000 claims abstract description 8
- 238000001959 radiotherapy Methods 0.000 claims abstract description 8
- 230000004258 retinal degeneration Effects 0.000 claims abstract description 8
- 201000000980 schizophrenia Diseases 0.000 claims abstract description 8
- 231100000886 tinnitus Toxicity 0.000 claims abstract description 8
- 208000006011 Stroke Diseases 0.000 claims abstract description 7
- 208000029560 autism spectrum disease Diseases 0.000 claims abstract description 7
- 229960003920 cocaine Drugs 0.000 claims abstract description 7
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229950010883 phencyclidine Drugs 0.000 claims abstract description 7
- 208000020431 spinal cord injury Diseases 0.000 claims abstract description 7
- 208000018737 Parkinson disease Diseases 0.000 claims abstract description 6
- 208000030886 Traumatic Brain injury Diseases 0.000 claims abstract description 6
- 230000009529 traumatic brain injury Effects 0.000 claims abstract description 6
- 125000006163 5-membered heteroaryl group Chemical group 0.000 claims abstract description 5
- 125000001072 heteroaryl group Chemical group 0.000 claims abstract description 4
- 125000006164 6-membered heteroaryl group Chemical group 0.000 claims abstract description 3
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 22
- 150000002431 hydrogen Chemical class 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 17
- 230000004766 neurogenesis Effects 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 14
- 235000019441 ethanol Nutrition 0.000 claims description 13
- 210000004556 brain Anatomy 0.000 claims description 12
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims description 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 10
- 230000006378 damage Effects 0.000 claims description 10
- WCZIYWJXOIRBFZ-UHFFFAOYSA-N 5H-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=NC=CCN2C1=CC=1C=C(C=CC21)C#N WCZIYWJXOIRBFZ-UHFFFAOYSA-N 0.000 claims description 9
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 8
- OUNFIHUIBCLDBP-UHFFFAOYSA-N 8-fluoro-6-(4-fluorophenyl)-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=CC(F)=CC=C1C1=CC(F)=CC2=C1N1CCNC(=O)C1=C2 OUNFIHUIBCLDBP-UHFFFAOYSA-N 0.000 claims description 7
- 238000002512 chemotherapy Methods 0.000 claims description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 7
- 230000035882 stress Effects 0.000 claims description 7
- HWHGRIMMWLJROG-UHFFFAOYSA-N 6-(3,4-difluorophenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(F)C(F)=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2 HWHGRIMMWLJROG-UHFFFAOYSA-N 0.000 claims description 6
- OTBWMOBGSRZNML-UHFFFAOYSA-N 8-chloro-6-(4-chlorophenyl)-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=CC(Cl)=CC=C1C1=CC(Cl)=CC2=C1N1CCNC(=O)C1=C2 OTBWMOBGSRZNML-UHFFFAOYSA-N 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- POEUJTXBABFXJV-UHFFFAOYSA-N 1-oxo-7-pyridin-3-yl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound O=C1NCCCN(C=23)C1=CC3=CC(C#N)=CC=2C1=CC=CN=C1 POEUJTXBABFXJV-UHFFFAOYSA-N 0.000 claims description 4
- AAOGBIVUHNMMNK-UHFFFAOYSA-N 11-methyl-7-(4-methylphenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CC=C(C)C=C1 AAOGBIVUHNMMNK-UHFFFAOYSA-N 0.000 claims description 4
- FKQYEUPDNPITME-UHFFFAOYSA-N 6-(3,4-dichlorophenyl)-8-fluoro-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC=1C=C(C=CC1Cl)C1=CC(=CC=2C(=C3N(C12)CCNC3=O)C)F FKQYEUPDNPITME-UHFFFAOYSA-N 0.000 claims description 4
- RSRQQGGSSMMYAY-UHFFFAOYSA-N 6-(3,4-difluorophenyl)-8-fluoro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(F)C(F)=C1 RSRQQGGSSMMYAY-UHFFFAOYSA-N 0.000 claims description 4
- NZAXDZCQWPGJRR-UHFFFAOYSA-N 6-(4-cyanophenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(C#N)C=C1 NZAXDZCQWPGJRR-UHFFFAOYSA-N 0.000 claims description 4
- REFADPCLVBMMER-UHFFFAOYSA-N 6-(4-fluorophenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=CC(F)=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2 REFADPCLVBMMER-UHFFFAOYSA-N 0.000 claims description 4
- DGEULJMOTKWIMT-UHFFFAOYSA-N 7-(3-chlorophenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound ClC1=CC=CC(C=2C=3N4CCCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 DGEULJMOTKWIMT-UHFFFAOYSA-N 0.000 claims description 4
- LAHYYYCXGWERMS-UHFFFAOYSA-N 7-(4-chloro-2-fluorophenyl)-11-methyl-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CC=C(Cl)C=C1F LAHYYYCXGWERMS-UHFFFAOYSA-N 0.000 claims description 4
- WCKDLQBDHIDDPI-UHFFFAOYSA-N 7-(4-chlorophenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=CC(Cl)=CC=C1C1=CC(C#N)=CC2=C1N1CCCNC(=O)C1=C2 WCKDLQBDHIDDPI-UHFFFAOYSA-N 0.000 claims description 4
- MQVDXEGVAONTPH-UHFFFAOYSA-N 8-chloro-10-methyl-6-pyrimidin-5-yl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(Cl)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CN=CN=C1 MQVDXEGVAONTPH-UHFFFAOYSA-N 0.000 claims description 4
- HDMUNQWVOGNVSI-UHFFFAOYSA-N 8-chloro-6-(3,4-difluorophenyl)-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(Cl)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(F)C(F)=C1 HDMUNQWVOGNVSI-UHFFFAOYSA-N 0.000 claims description 4
- RBIYKEZFYDIGFC-UHFFFAOYSA-N 8-fluoro-6-[4-(trifluoromethyl)phenyl]-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C=12N3CCNC(=O)C3=CC2=CC(F)=CC=1C1=CC=C(C(F)(F)F)C=C1 RBIYKEZFYDIGFC-UHFFFAOYSA-N 0.000 claims description 4
- 208000035475 disorder Diseases 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- QPLGPMBJYOLMFR-UHFFFAOYSA-N 1-oxo-6-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-2H-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound O=C1NCCN2C1=CC=1C=C(C=C(C21)C2=CC=C(C=C2)OC(F)(F)F)C#N QPLGPMBJYOLMFR-UHFFFAOYSA-N 0.000 claims description 3
- RUBRDPCQPUSZHN-UHFFFAOYSA-N 1-oxo-6-pyridin-4-yl-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound O=C1NCCN(C=23)C1=CC3=CC(C#N)=CC=2C1=CC=NC=C1 RUBRDPCQPUSZHN-UHFFFAOYSA-N 0.000 claims description 3
- LHJBTKJTUQMCBA-UHFFFAOYSA-N 1-oxo-7-(2,3,4-trifluorophenyl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound FC1=C(F)C(F)=CC=C1C1=CC(C#N)=CC2=C1N1CCCNC(=O)C1=C2 LHJBTKJTUQMCBA-UHFFFAOYSA-N 0.000 claims description 3
- ABNQZWZZDRESKI-UHFFFAOYSA-N 10-methyl-1-oxo-6-(2,3,4-trifluorophenyl)-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(F)C(F)=C1F ABNQZWZZDRESKI-UHFFFAOYSA-N 0.000 claims description 3
- HJRUOBGPDLWYIX-UHFFFAOYSA-N 10-methyl-1-oxo-6-(3,4,5-trifluorophenyl)-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC(F)=C(F)C(F)=C1 HJRUOBGPDLWYIX-UHFFFAOYSA-N 0.000 claims description 3
- KXCRGRHSMBICFT-UHFFFAOYSA-N 10-methyl-1-oxo-6-[4-(trifluoromethyl)phenyl]-3,4-dihydro-2H-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound Cc1c2C(=O)NCCn2c2c(cc(cc12)C#N)-c1ccc(cc1)C(F)(F)F KXCRGRHSMBICFT-UHFFFAOYSA-N 0.000 claims description 3
- NGGLBNYXRXYNBF-UHFFFAOYSA-N 10-methyl-1-oxo-6-pyridin-4-yl-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=NC=C1 NGGLBNYXRXYNBF-UHFFFAOYSA-N 0.000 claims description 3
- YOWPSWMMKLYIAC-UHFFFAOYSA-N 10-methyl-1-oxo-6-pyrimidin-5-yl-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CN=CN=C1 YOWPSWMMKLYIAC-UHFFFAOYSA-N 0.000 claims description 3
- DJKJVHMYBBHJFT-UHFFFAOYSA-N 10-methyl-6-(4-nitrophenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C([N+]([O-])=O)C=C1 DJKJVHMYBBHJFT-UHFFFAOYSA-N 0.000 claims description 3
- JYCYVBFESAAZDR-UHFFFAOYSA-N 3-(8-fluoro-10-methyl-1-oxo-3,4-dihydro-2H-pyrazino[1,2-a]indol-6-yl)benzonitrile Chemical compound FC1=CC=2C(=C3N(C2C(=C1)C=1C=C(C#N)C=CC1)CCNC3=O)C JYCYVBFESAAZDR-UHFFFAOYSA-N 0.000 claims description 3
- BGBPYCMCJVNLNW-UHFFFAOYSA-N 4-(8-chloro-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indol-6-yl)benzonitrile Chemical compound C1=C(Cl)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(C#N)C=C1 BGBPYCMCJVNLNW-UHFFFAOYSA-N 0.000 claims description 3
- BYUCLUSQMOHVNU-UHFFFAOYSA-N 4-(8-fluoro-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indol-6-yl)benzonitrile Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(C#N)C=C1 BYUCLUSQMOHVNU-UHFFFAOYSA-N 0.000 claims description 3
- VTODNOUFAFSKBM-UHFFFAOYSA-N 6-(2,4-dichlorophenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound ClC1=CC(Cl)=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2 VTODNOUFAFSKBM-UHFFFAOYSA-N 0.000 claims description 3
- QTWZNPNPCPBHIW-UHFFFAOYSA-N 6-(2,4-dichlorophenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(Cl)C=C1Cl QTWZNPNPCPBHIW-UHFFFAOYSA-N 0.000 claims description 3
- WKMOIRNRRIFVDH-UHFFFAOYSA-N 6-(2,4-difluorophenyl)-1-oxo-3,4-dihydro-2H-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound Fc1ccc(c(F)c1)-c1cc(cc2cc3C(=O)NCCn3c12)C#N WKMOIRNRRIFVDH-UHFFFAOYSA-N 0.000 claims description 3
- RDXZOAYIZVXGED-UHFFFAOYSA-N 6-(2,4-difluorophenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(F)C=C1F RDXZOAYIZVXGED-UHFFFAOYSA-N 0.000 claims description 3
- HSJGJSINRADNHG-UHFFFAOYSA-N 6-(2,4-difluorophenyl)-8-fluoro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(F)C=C1F HSJGJSINRADNHG-UHFFFAOYSA-N 0.000 claims description 3
- OAIWBLDVWSIAQU-UHFFFAOYSA-N 6-(2-chloropyridin-4-yl)-8-fluoro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=NC(Cl)=C1 OAIWBLDVWSIAQU-UHFFFAOYSA-N 0.000 claims description 3
- TYCRPYGACMXXFT-UHFFFAOYSA-N 6-(2-fluoropyridin-4-yl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=NC(F)=CC(C=2C=3N4CCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 TYCRPYGACMXXFT-UHFFFAOYSA-N 0.000 claims description 3
- LOESOHTVKCRGNK-UHFFFAOYSA-N 6-(2-fluoropyridin-4-yl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=NC(F)=C1 LOESOHTVKCRGNK-UHFFFAOYSA-N 0.000 claims description 3
- DXSDRGRXCBLODQ-UHFFFAOYSA-N 6-(3,4-difluorophenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(F)C(F)=C1 DXSDRGRXCBLODQ-UHFFFAOYSA-N 0.000 claims description 3
- GGGACKZJNREVTH-UHFFFAOYSA-N 6-(3,4-difluorophenyl)-8-fluoro-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C=12N3CCNC(=O)C3=CC2=CC(F)=CC=1C1=CC=C(F)C(F)=C1 GGGACKZJNREVTH-UHFFFAOYSA-N 0.000 claims description 3
- HEGRZGFLEIRAJL-UHFFFAOYSA-N 6-(3,5-difluorophenyl)-8-fluoro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC(F)=CC(F)=C1 HEGRZGFLEIRAJL-UHFFFAOYSA-N 0.000 claims description 3
- JUQMNLHQIQLGFU-UHFFFAOYSA-N 6-(3-chlorophenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=CC(Cl)=C1 JUQMNLHQIQLGFU-UHFFFAOYSA-N 0.000 claims description 3
- ASSRQRHDZUZDRY-UHFFFAOYSA-N 6-(3-chlorophenyl)-8-fluoro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=CC(Cl)=C1 ASSRQRHDZUZDRY-UHFFFAOYSA-N 0.000 claims description 3
- BEBYOQMOQPGLQU-UHFFFAOYSA-N 6-(3-fluoro-4-methylphenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(F)C(C)=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2 BEBYOQMOQPGLQU-UHFFFAOYSA-N 0.000 claims description 3
- BBHOBGCOQCPQGD-UHFFFAOYSA-N 6-(3-fluoro-4-methylphenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(C)C(F)=C1 BBHOBGCOQCPQGD-UHFFFAOYSA-N 0.000 claims description 3
- NBEPAVGDYHKZDK-UHFFFAOYSA-N 6-(4-chloro-2-fluorophenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound FC1=CC(Cl)=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2 NBEPAVGDYHKZDK-UHFFFAOYSA-N 0.000 claims description 3
- ZSTGVWJDEYDPGX-UHFFFAOYSA-N 6-(4-chloro-3-fluorophenyl)-1-oxo-3,4-dihydro-2H-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound Fc1cc(ccc1Cl)-c1cc(cc2cc3C(=O)NCCn3c12)C#N ZSTGVWJDEYDPGX-UHFFFAOYSA-N 0.000 claims description 3
- UEEQRAIWXXLSLV-UHFFFAOYSA-N 6-(4-chloro-3-fluorophenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(Cl)C(F)=C1 UEEQRAIWXXLSLV-UHFFFAOYSA-N 0.000 claims description 3
- YLSLASTYBBSEFH-UHFFFAOYSA-N 6-(4-chloro-3-fluorophenyl)-8-fluoro-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC1=C(C=C(C=C1)C1=CC(=CC=2C(=C3N(C12)CCNC3=O)C)F)F YLSLASTYBBSEFH-UHFFFAOYSA-N 0.000 claims description 3
- VCBJFXDWPBEAOU-UHFFFAOYSA-N 6-(4-chlorophenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=CC(Cl)=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2 VCBJFXDWPBEAOU-UHFFFAOYSA-N 0.000 claims description 3
- NTXAUUFUZCWGDC-UHFFFAOYSA-N 6-(4-chlorophenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(Cl)C=C1 NTXAUUFUZCWGDC-UHFFFAOYSA-N 0.000 claims description 3
- FNKUAFXYGHPFMX-UHFFFAOYSA-N 6-(4-chlorophenyl)-7,8-difluoro-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound FC=1C(F)=CC=2C=C3C(=O)NCCN3C=2C=1C1=CC=C(Cl)C=C1 FNKUAFXYGHPFMX-UHFFFAOYSA-N 0.000 claims description 3
- AZLIAKJSWGWHQD-UHFFFAOYSA-N 6-(4-chlorophenyl)-8-methoxy-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C=12N3CCNC(=O)C3=CC2=CC(OC)=CC=1C1=CC=C(Cl)C=C1 AZLIAKJSWGWHQD-UHFFFAOYSA-N 0.000 claims description 3
- FOXZHDGLKMYZOG-UHFFFAOYSA-N 6-(4-chlorophenyl)-8-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C=12N3CCNC(=O)C3=CC2=CC(C)=CC=1C1=CC=C(Cl)C=C1 FOXZHDGLKMYZOG-UHFFFAOYSA-N 0.000 claims description 3
- QDIOYOTYKUXIEQ-UHFFFAOYSA-N 6-(4-cyanophenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound O=C1NCCN(C=23)C1=CC3=CC(C#N)=CC=2C1=CC=C(C#N)C=C1 QDIOYOTYKUXIEQ-UHFFFAOYSA-N 0.000 claims description 3
- UNNOFFJGNHCPSO-UHFFFAOYSA-N 6-(4-methoxyphenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=CC(OC)=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2 UNNOFFJGNHCPSO-UHFFFAOYSA-N 0.000 claims description 3
- XSPRAIUJAUNPRX-UHFFFAOYSA-N 6-(4-methoxyphenyl)-8-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=CC(OC)=CC=C1C1=CC(C)=CC2=C1N1CCNC(=O)C1=C2 XSPRAIUJAUNPRX-UHFFFAOYSA-N 0.000 claims description 3
- FOWIKKMUDLZMJC-UHFFFAOYSA-N 6-(4-tert-butylphenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(C(C)(C)C)C=C1 FOWIKKMUDLZMJC-UHFFFAOYSA-N 0.000 claims description 3
- SIVHZTVYHJJYSD-UHFFFAOYSA-N 6-(4-tert-butylphenyl)-8-chloro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(Cl)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(C(C)(C)C)C=C1 SIVHZTVYHJJYSD-UHFFFAOYSA-N 0.000 claims description 3
- NTDVNKUMOUWYPL-UHFFFAOYSA-N 6-(6-aminopyridin-3-yl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=NC(N)=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2 NTDVNKUMOUWYPL-UHFFFAOYSA-N 0.000 claims description 3
- VZMRSQLRLNOKJS-UHFFFAOYSA-N 6-(6-chloropyridin-3-yl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(Cl)N=C1 VZMRSQLRLNOKJS-UHFFFAOYSA-N 0.000 claims description 3
- JYFGPDZHFYBPPH-UHFFFAOYSA-N 6-(6-fluoropyridin-3-yl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(F)N=C1 JYFGPDZHFYBPPH-UHFFFAOYSA-N 0.000 claims description 3
- HSVRLDIWXDDPFC-UHFFFAOYSA-N 6-[4-(dimethylamino)phenyl]-8-fluoro-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound CN(C1=CC=C(C=C1)C1=CC(=CC=2C(=C3N(C12)CCNC3=O)C)F)C HSVRLDIWXDDPFC-UHFFFAOYSA-N 0.000 claims description 3
- SZSDTHBAUBXJCD-UHFFFAOYSA-N 7-(2,4-dichlorophenyl)-11-methyl-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CC=C(Cl)C=C1Cl SZSDTHBAUBXJCD-UHFFFAOYSA-N 0.000 claims description 3
- USAQYUICZIWTCX-UHFFFAOYSA-N 7-(2,4-difluorophenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound FC1=CC(F)=CC=C1C1=CC(C#N)=CC2=C1N1CCCNC(=O)C1=C2 USAQYUICZIWTCX-UHFFFAOYSA-N 0.000 claims description 3
- BLOJDUYHCZRFJS-UHFFFAOYSA-N 7-(2-fluoropyridin-4-yl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=NC(F)=CC(C=2C=3N4CCCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 BLOJDUYHCZRFJS-UHFFFAOYSA-N 0.000 claims description 3
- CFSYPCFJIPBYOQ-UHFFFAOYSA-N 7-(3,4-dichlorophenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(Cl)C(Cl)=CC=C1C1=CC(C#N)=CC2=C1N1CCCNC(=O)C1=C2 CFSYPCFJIPBYOQ-UHFFFAOYSA-N 0.000 claims description 3
- IBNKBBCECLHYFQ-UHFFFAOYSA-N 7-(3,4-dichlorophenyl)-11-methyl-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CC=C(Cl)C(Cl)=C1 IBNKBBCECLHYFQ-UHFFFAOYSA-N 0.000 claims description 3
- MZFZMUBJNLFCOK-UHFFFAOYSA-N 7-(3,4-difluorophenyl)-8,9-difluoro-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1=C(F)C(F)=CC=C1C1=C(F)C(F)=CC2=C1N1CCCNC(=O)C1=C2 MZFZMUBJNLFCOK-UHFFFAOYSA-N 0.000 claims description 3
- MZGCXEPGMHVUFD-UHFFFAOYSA-N 7-(3,5-difluorophenyl)-11-methyl-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CC(F)=CC(F)=C1 MZGCXEPGMHVUFD-UHFFFAOYSA-N 0.000 claims description 3
- FQMDEFOFYYKASG-UHFFFAOYSA-N 7-(3-fluoro-4-methylphenyl)-11-methyl-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CC=C(C)C(F)=C1 FQMDEFOFYYKASG-UHFFFAOYSA-N 0.000 claims description 3
- YIKFDFLGQPRJKE-UHFFFAOYSA-N 7-(3-fluorophenyl)-11-methyl-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CC=CC(F)=C1 YIKFDFLGQPRJKE-UHFFFAOYSA-N 0.000 claims description 3
- HHLAUBWQJFXEOB-UHFFFAOYSA-N 7-(4-chloro-2-fluorophenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound FC1=CC(Cl)=CC=C1C1=CC(C#N)=CC2=C1N1CCCNC(=O)C1=C2 HHLAUBWQJFXEOB-UHFFFAOYSA-N 0.000 claims description 3
- PFOUHFMPQKXVEL-UHFFFAOYSA-N 7-(4-chloro-3-fluorophenyl)-11-methyl-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CC=C(Cl)C(F)=C1 PFOUHFMPQKXVEL-UHFFFAOYSA-N 0.000 claims description 3
- NRCJYXDYASZUKJ-UHFFFAOYSA-N 7-(4-chlorophenyl)-11-methyl-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CC=C(Cl)C=C1 NRCJYXDYASZUKJ-UHFFFAOYSA-N 0.000 claims description 3
- SIQGKKNWRPATKD-UHFFFAOYSA-N 7-(4-cyanophenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound O=C1NCCCN(C=23)C1=CC3=CC(C#N)=CC=2C1=CC=C(C#N)C=C1 SIQGKKNWRPATKD-UHFFFAOYSA-N 0.000 claims description 3
- WQHFBSQONNZURZ-UHFFFAOYSA-N 7-(4-cyanophenyl)-11-methyl-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound Cc1c2C(=O)NCCCn2c2c(cc(cc12)C#N)-c1ccc(cc1)C#N WQHFBSQONNZURZ-UHFFFAOYSA-N 0.000 claims description 3
- HNHSZZUONRNWGO-UHFFFAOYSA-N 7-(4-fluoro-3-methylphenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(F)C(C)=CC(C=2C=3N4CCCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 HNHSZZUONRNWGO-UHFFFAOYSA-N 0.000 claims description 3
- XRXOOUOWNXCGSC-UHFFFAOYSA-N 7-(4-fluorophenyl)-11-methyl-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CC=C(F)C=C1 XRXOOUOWNXCGSC-UHFFFAOYSA-N 0.000 claims description 3
- VJPPNMMZYFBKPU-UHFFFAOYSA-N 7-(4-methoxyphenyl)-11-methyl-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=CC(OC)=CC=C1C1=CC(C#N)=CC2=C1N1CCCNC(=O)C1=C2C VJPPNMMZYFBKPU-UHFFFAOYSA-N 0.000 claims description 3
- NLTPEBMQZBSKJF-UHFFFAOYSA-N 7-(4-methylsulfonylphenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=CC(C#N)=CC2=C1N1CCCNC(=O)C1=C2 NLTPEBMQZBSKJF-UHFFFAOYSA-N 0.000 claims description 3
- NIPQMYPTDBNHPJ-UHFFFAOYSA-N 7-(4-tert-butylphenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=CC(C(C)(C)C)=CC=C1C1=CC(C#N)=CC2=C1N1CCCNC(=O)C1=C2 NIPQMYPTDBNHPJ-UHFFFAOYSA-N 0.000 claims description 3
- KPSWXJYXTHRCJW-UHFFFAOYSA-N 7-(6-aminopyridin-3-yl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=NC(N)=CC=C1C1=CC(C#N)=CC2=C1N1CCCNC(=O)C1=C2 KPSWXJYXTHRCJW-UHFFFAOYSA-N 0.000 claims description 3
- QQPUBJUSQLTVFO-UHFFFAOYSA-N 7-(6-chloropyridin-3-yl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=NC(Cl)=CC=C1C1=CC(C#N)=CC2=C1N1CCCNC(=O)C1=C2 QQPUBJUSQLTVFO-UHFFFAOYSA-N 0.000 claims description 3
- AKNKPOJMIBYJOA-UHFFFAOYSA-N 7-[4-(hydroxymethyl)phenyl]-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=CC(CO)=CC=C1C1=CC(C#N)=CC2=C1N1CCCNC(=O)C1=C2 AKNKPOJMIBYJOA-UHFFFAOYSA-N 0.000 claims description 3
- DPEBSEFDHRXGPE-UHFFFAOYSA-N 7-[4-chloro-3-(trifluoromethyl)phenyl]-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(C=2C=3N4CCCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 DPEBSEFDHRXGPE-UHFFFAOYSA-N 0.000 claims description 3
- VBXCBFSVTONPOL-UHFFFAOYSA-N 8-chloro-10-methyl-6-(3,4,5-trifluorophenyl)-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC1=CC=2C(=C3N(C2C(=C1)C1=CC(=C(C(=C1)F)F)F)CCNC3=O)C VBXCBFSVTONPOL-UHFFFAOYSA-N 0.000 claims description 3
- KACYJAGVUYBDLR-UHFFFAOYSA-N 8-chloro-10-methyl-6-(4-methylphenyl)-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(Cl)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(C)C=C1 KACYJAGVUYBDLR-UHFFFAOYSA-N 0.000 claims description 3
- QLAMVQRQLFUHIL-UHFFFAOYSA-N 8-chloro-10-methyl-6-(4-nitrophenyl)-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(Cl)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C([N+]([O-])=O)C=C1 QLAMVQRQLFUHIL-UHFFFAOYSA-N 0.000 claims description 3
- PTCAJQZBCDBVPI-UHFFFAOYSA-N 8-chloro-10-methyl-6-pyridin-4-yl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(Cl)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=NC=C1 PTCAJQZBCDBVPI-UHFFFAOYSA-N 0.000 claims description 3
- OOGHIFTZICFPRG-UHFFFAOYSA-N 8-chloro-6-(2-fluoropyridin-4-yl)-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC1=CC=2C(=C3N(C2C(=C1)C1=CC(=NC=C1)F)CCNC3=O)C OOGHIFTZICFPRG-UHFFFAOYSA-N 0.000 claims description 3
- FGROROAZWMLICU-UHFFFAOYSA-N 8-chloro-6-(2-methoxypyrimidin-5-yl)-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=NC(OC)=NC=C1C1=CC(Cl)=CC2=C1N1CCNC(=O)C1=C2C FGROROAZWMLICU-UHFFFAOYSA-N 0.000 claims description 3
- SQPFCOPYIJSHTF-UHFFFAOYSA-N 8-chloro-6-(3,4-dichlorophenyl)-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound Cc1c2C(=O)NCCn2c2c(cc(Cl)cc12)-c1ccc(Cl)c(Cl)c1 SQPFCOPYIJSHTF-UHFFFAOYSA-N 0.000 claims description 3
- XYTKPALNLTXFOC-UHFFFAOYSA-N 8-chloro-6-(3-fluoro-4-methylphenyl)-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound Cc1c2C(=O)NCCn2c2c(cc(Cl)cc12)-c1ccc(C)c(F)c1 XYTKPALNLTXFOC-UHFFFAOYSA-N 0.000 claims description 3
- JHAWLQCHHRIBAQ-UHFFFAOYSA-N 8-chloro-6-(4-fluoro-3-methylphenyl)-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC1=CC=2C(=C3N(C2C(=C1)C1=CC(=C(C=C1)F)C)CCNC3=O)C JHAWLQCHHRIBAQ-UHFFFAOYSA-N 0.000 claims description 3
- OBQPXGHMSVAMLB-UHFFFAOYSA-N 8-chloro-6-(4-methoxyphenyl)-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=CC(OC)=CC=C1C1=CC(Cl)=CC2=C1N1CCNC(=O)C1=C2C OBQPXGHMSVAMLB-UHFFFAOYSA-N 0.000 claims description 3
- NGQOYZKVLWFGGZ-UHFFFAOYSA-N 8-chloro-6-[4-(hydroxymethyl)phenyl]-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(Cl)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(CO)C=C1 NGQOYZKVLWFGGZ-UHFFFAOYSA-N 0.000 claims description 3
- NCHLKKLZGATARS-UHFFFAOYSA-N 8-fluoro-10-methyl-6-(1,3-thiazol-2-yl)-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=NC=CS1 NCHLKKLZGATARS-UHFFFAOYSA-N 0.000 claims description 3
- WOHKQECHZQZMPJ-UHFFFAOYSA-N 8-fluoro-10-methyl-6-(3,4,5-trifluorophenyl)-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound FC1=CC=2C(=C3N(C2C(=C1)C1=CC(=C(C(=C1)F)F)F)CCNC3=O)C WOHKQECHZQZMPJ-UHFFFAOYSA-N 0.000 claims description 3
- ZJYGLVXGOMTLAM-UHFFFAOYSA-N 8-fluoro-10-methyl-6-(4-methylphenyl)-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(C)C=C1 ZJYGLVXGOMTLAM-UHFFFAOYSA-N 0.000 claims description 3
- QRLZPNDWKCEOHJ-UHFFFAOYSA-N 8-fluoro-6-(2-methoxypyrimidin-5-yl)-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=NC(OC)=NC=C1C1=CC(F)=CC2=C1N1CCNC(=O)C1=C2C QRLZPNDWKCEOHJ-UHFFFAOYSA-N 0.000 claims description 3
- HGAKHSUJPNSXIF-UHFFFAOYSA-N 8-fluoro-6-(3-fluorophenyl)-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound FC1=CC=2C(=C3N(C2C(=C1)C1=CC(=CC=C1)F)CCNC3=O)C HGAKHSUJPNSXIF-UHFFFAOYSA-N 0.000 claims description 3
- QHBVNQGEYKFOFS-UHFFFAOYSA-N 8-fluoro-6-(4-fluorophenyl)-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(F)C=C1 QHBVNQGEYKFOFS-UHFFFAOYSA-N 0.000 claims description 3
- MAPRLTKQBIUHGN-UHFFFAOYSA-N 8-fluoro-6-(4-fluorophenyl)-2-methyl-3,4-dihydropyrazino[1,2-a]indol-1-one Chemical compound O=C1N(C)CCN(C=23)C1=CC3=CC(F)=CC=2C1=CC=C(F)C=C1 MAPRLTKQBIUHGN-UHFFFAOYSA-N 0.000 claims description 3
- VXAPANAKKDWEIE-UHFFFAOYSA-N 8-fluoro-6-(4-methylphenyl)-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound Cc1ccc(cc1)-c1cc(F)cc2cc3C(=O)NCCn3c12 VXAPANAKKDWEIE-UHFFFAOYSA-N 0.000 claims description 3
- NTFLONCFDPIGBN-UHFFFAOYSA-N 8-fluoro-6-phenyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C=12N3CCNC(=O)C3=CC2=CC(F)=CC=1C1=CC=CC=C1 NTFLONCFDPIGBN-UHFFFAOYSA-N 0.000 claims description 3
- WLUXTEZMDFLZAR-UHFFFAOYSA-N 9-chloro-7-(3,4-difluorophenyl)-11-methyl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound Cc1c2C(=O)NCCCn2c2c(cc(Cl)cc12)-c1ccc(F)c(F)c1 WLUXTEZMDFLZAR-UHFFFAOYSA-N 0.000 claims description 3
- BCIPDARFIBFOJJ-UHFFFAOYSA-N 9-chloro-7-(3,4-difluorophenyl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1=C(F)C(F)=CC=C1C1=CC(Cl)=CC2=C1N1CCCNC(=O)C1=C2 BCIPDARFIBFOJJ-UHFFFAOYSA-N 0.000 claims description 3
- JKFBZJUPHJGUBB-UHFFFAOYSA-N 9-chloro-7-(4-methoxyphenyl)-11-methyl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1=CC(OC)=CC=C1C1=CC(Cl)=CC2=C1N1CCCNC(=O)C1=C2C JKFBZJUPHJGUBB-UHFFFAOYSA-N 0.000 claims description 3
- FAGXZRUFRBTRCD-UHFFFAOYSA-N 9-chloro-7-(4-methoxyphenyl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1=CC(OC)=CC=C1C1=CC(Cl)=CC2=C1N1CCCNC(=O)C1=C2 FAGXZRUFRBTRCD-UHFFFAOYSA-N 0.000 claims description 3
- UOZQVAZIEBZKOW-UHFFFAOYSA-N 9-chloro-7-(4-methylphenyl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1=CC(C)=CC=C1C1=CC(Cl)=CC2=C1N1CCCNC(=O)C1=C2 UOZQVAZIEBZKOW-UHFFFAOYSA-N 0.000 claims description 3
- QZXIFOIZDPARGI-UHFFFAOYSA-N 9-fluoro-7-phenyl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C=12N3CCCNC(=O)C3=CC2=CC(F)=CC=1C1=CC=CC=C1 QZXIFOIZDPARGI-UHFFFAOYSA-N 0.000 claims description 3
- WGMVDBWTEDWTQD-UHFFFAOYSA-N 9-fluoro-7-pyridin-4-yl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C=12N3CCCNC(=O)C3=CC2=CC(F)=CC=1C1=CC=NC=C1 WGMVDBWTEDWTQD-UHFFFAOYSA-N 0.000 claims description 3
- 239000013543 active substance Substances 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- 238000011321 prophylaxis Methods 0.000 claims description 3
- 125000004076 pyridyl group Chemical group 0.000 claims description 3
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 3
- AYUAHDMNPBUDKY-UHFFFAOYSA-N 1-oxo-6-[4-(trifluoromethyl)phenyl]-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2 AYUAHDMNPBUDKY-UHFFFAOYSA-N 0.000 claims description 2
- QJAWIZDUDIMZJT-UHFFFAOYSA-N 1-oxo-7-[4-(trifluoromethoxy)phenyl]-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=CC(OC(F)(F)F)=CC=C1C1=CC(C#N)=CC2=C1N1CCCNC(=O)C1=C2 QJAWIZDUDIMZJT-UHFFFAOYSA-N 0.000 claims description 2
- AGVXVEOXZMNLPW-UHFFFAOYSA-N 1-oxo-7-[4-(trifluoromethyl)phenyl]-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=CC(C#N)=CC2=C1N1CCCNC(=O)C1=C2 AGVXVEOXZMNLPW-UHFFFAOYSA-N 0.000 claims description 2
- OAYFICPXUJWQQS-UHFFFAOYSA-N 1-oxo-7-phenyl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound O=C1NCCCN(C=23)C1=CC3=CC(C#N)=CC=2C1=CC=CC=C1 OAYFICPXUJWQQS-UHFFFAOYSA-N 0.000 claims description 2
- NUEJMBPCFDLETM-UHFFFAOYSA-N 10-methyl-1-oxo-6-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-2H-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound Cc1c2C(=O)NCCn2c2c(cc(cc12)C#N)-c1ccc(OC(F)(F)F)cc1 NUEJMBPCFDLETM-UHFFFAOYSA-N 0.000 claims description 2
- RZGZWWNRYXWOHD-UHFFFAOYSA-N 10-methyl-1-oxo-6-phenyl-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=CC=C1 RZGZWWNRYXWOHD-UHFFFAOYSA-N 0.000 claims description 2
- NMZXXNWFBDTICD-UHFFFAOYSA-N 10-methyl-1-oxo-6-pyridin-3-yl-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=CN=C1 NMZXXNWFBDTICD-UHFFFAOYSA-N 0.000 claims description 2
- JSDTUCOPSABVNO-UHFFFAOYSA-N 10-methyl-6-(4-methylphenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(C)C=C1 JSDTUCOPSABVNO-UHFFFAOYSA-N 0.000 claims description 2
- PUZLOZXFYLSIOX-UHFFFAOYSA-N 11-methyl-1-oxo-7-(3,4,5-trifluorophenyl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CC(F)=C(F)C(F)=C1 PUZLOZXFYLSIOX-UHFFFAOYSA-N 0.000 claims description 2
- JSUUAGGCKBHEGP-UHFFFAOYSA-N 11-methyl-1-oxo-7-[4-(trifluoromethyl)phenyl]-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CC=C(C(F)(F)F)C=C1 JSUUAGGCKBHEGP-UHFFFAOYSA-N 0.000 claims description 2
- WYKQJJWWFKJCFN-UHFFFAOYSA-N 11-methyl-1-oxo-7-phenyl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CC=CC=C1 WYKQJJWWFKJCFN-UHFFFAOYSA-N 0.000 claims description 2
- AWNDLFKBFSGLJI-UHFFFAOYSA-N 11-methyl-1-oxo-7-pyridin-4-yl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CC=NC=C1 AWNDLFKBFSGLJI-UHFFFAOYSA-N 0.000 claims description 2
- SSEIHZQDVQMNRG-UHFFFAOYSA-N 3-(8-chloro-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indol-6-yl)benzonitrile Chemical compound C1=C(Cl)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=CC(C#N)=C1 SSEIHZQDVQMNRG-UHFFFAOYSA-N 0.000 claims description 2
- ZSNZOQSRFCVFDY-UHFFFAOYSA-N 5-(8-fluoro-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indol-6-yl)thiophene-2-carbonitrile Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(C#N)S1 ZSNZOQSRFCVFDY-UHFFFAOYSA-N 0.000 claims description 2
- MCLSQXOEPSEUGA-UHFFFAOYSA-N 6-(1,3-benzodioxol-5-yl)-8-fluoro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C2OCOC2=CC(C2=C3N4CCNC(=O)C4=C(C3=CC(F)=C2)C)=C1 MCLSQXOEPSEUGA-UHFFFAOYSA-N 0.000 claims description 2
- KBXOBGUHDPLHMI-UHFFFAOYSA-N 6-(2,3-dihydro-1-benzofuran-5-yl)-8-fluoro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C2OCCC2=CC(C2=C3N4CCNC(=O)C4=C(C3=CC(F)=C2)C)=C1 KBXOBGUHDPLHMI-UHFFFAOYSA-N 0.000 claims description 2
- LHNSWWGOYGLBDY-UHFFFAOYSA-N 6-(2,4-dichlorophenyl)-8-fluoro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(Cl)C=C1Cl LHNSWWGOYGLBDY-UHFFFAOYSA-N 0.000 claims description 2
- WMQCMCIQMABWNF-UHFFFAOYSA-N 6-(2-aminopyrimidin-5-yl)-8-fluoro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CN=C(N)N=C1 WMQCMCIQMABWNF-UHFFFAOYSA-N 0.000 claims description 2
- SUQIITGZNCZJHB-UHFFFAOYSA-N 6-(3,4-dichlorophenyl)-1-oxo-3,4-dihydro-2H-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound ClC=1C=C(C=CC1Cl)C1=CC(=CC=2C=C3N(C12)CCNC3=O)C#N SUQIITGZNCZJHB-UHFFFAOYSA-N 0.000 claims description 2
- AIDOTKFYRRRJMN-UHFFFAOYSA-N 6-(3,4-difluorophenyl)-1-oxo-10-(trifluoromethyl)-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(F)C(F)=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2C(F)(F)F AIDOTKFYRRRJMN-UHFFFAOYSA-N 0.000 claims description 2
- IATPTQAKKUFLQT-UHFFFAOYSA-N 6-(3,4-difluorophenyl)-7,8-difluoro-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C(F)=CC=C1C1=C(F)C(F)=CC2=C1N1CCNC(=O)C1=C2 IATPTQAKKUFLQT-UHFFFAOYSA-N 0.000 claims description 2
- RCJWUZCYDDPNFL-UHFFFAOYSA-N 6-(3,4-difluorophenyl)-8,9-difluoro-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C(F)=CC=C1C1=CC(F)=C(F)C2=C1N1CCNC(=O)C1=C2 RCJWUZCYDDPNFL-UHFFFAOYSA-N 0.000 claims description 2
- HLZAVOFFBYTBSG-UHFFFAOYSA-N 6-(3,4-difluorophenyl)-8-methoxy-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C=12N3CCNC(=O)C3=CC2=CC(OC)=CC=1C1=CC=C(F)C(F)=C1 HLZAVOFFBYTBSG-UHFFFAOYSA-N 0.000 claims description 2
- VHXDIMVZZDQBAF-UHFFFAOYSA-N 6-(3,4-difluorophenyl)-8-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C=12N3CCNC(=O)C3=CC2=CC(C)=CC=1C1=CC=C(F)C(F)=C1 VHXDIMVZZDQBAF-UHFFFAOYSA-N 0.000 claims description 2
- ATRAOJYWBQOBSR-UHFFFAOYSA-N 6-(3,5-difluorophenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound FC1=CC(F)=CC(C=2C=3N4CCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 ATRAOJYWBQOBSR-UHFFFAOYSA-N 0.000 claims description 2
- DBFPOHJJSRPUHF-UHFFFAOYSA-N 6-(3-chlorophenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound ClC1=CC=CC(C=2C=3N4CCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 DBFPOHJJSRPUHF-UHFFFAOYSA-N 0.000 claims description 2
- HXQKBPMDYZQCBH-UHFFFAOYSA-N 6-(3-cyanophenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound O=C1NCCN(C=23)C1=CC3=CC(C#N)=CC=2C1=CC=CC(C#N)=C1 HXQKBPMDYZQCBH-UHFFFAOYSA-N 0.000 claims description 2
- DKFVQOQYFRTAHM-UHFFFAOYSA-N 6-(3-cyanophenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=CC(C#N)=C1 DKFVQOQYFRTAHM-UHFFFAOYSA-N 0.000 claims description 2
- DZNRHOQZLNIETJ-UHFFFAOYSA-N 6-(3-fluorophenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound FC1=CC=CC(C=2C=3N4CCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 DZNRHOQZLNIETJ-UHFFFAOYSA-N 0.000 claims description 2
- RCSFCAOMRJJPBD-UHFFFAOYSA-N 6-(4-chloro-2-fluorophenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(Cl)C=C1F RCSFCAOMRJJPBD-UHFFFAOYSA-N 0.000 claims description 2
- YJDBGBCBLPNVJP-UHFFFAOYSA-N 6-(4-chlorophenyl)-8,9-difluoro-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C=12N3CCNC(=O)C3=CC2=C(F)C(F)=CC=1C1=CC=C(Cl)C=C1 YJDBGBCBLPNVJP-UHFFFAOYSA-N 0.000 claims description 2
- LCGKOOZXZWJDNV-UHFFFAOYSA-N 6-(4-chlorophenyl)-8-fluoro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(Cl)C=C1 LCGKOOZXZWJDNV-UHFFFAOYSA-N 0.000 claims description 2
- QGWVTKNGSPBCPN-UHFFFAOYSA-N 6-(4-chlorophenyl)-8-fluoro-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C=12N3CCNC(=O)C3=CC2=CC(F)=CC=1C1=CC=C(Cl)C=C1 QGWVTKNGSPBCPN-UHFFFAOYSA-N 0.000 claims description 2
- SVVQFPXWAQHOAN-UHFFFAOYSA-N 6-(4-fluoro-3-methylphenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(F)C(C)=C1 SVVQFPXWAQHOAN-UHFFFAOYSA-N 0.000 claims description 2
- GQSQRTKNVLSCTG-UHFFFAOYSA-N 6-(4-fluorophenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(F)C=C1 GQSQRTKNVLSCTG-UHFFFAOYSA-N 0.000 claims description 2
- BMRDPTIKODLEPY-UHFFFAOYSA-N 6-(4-fluorophenyl)-8-methoxy-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C=12N3CCNC(=O)C3=CC2=CC(OC)=CC=1C1=CC=C(F)C=C1 BMRDPTIKODLEPY-UHFFFAOYSA-N 0.000 claims description 2
- YPDUMRZFRFBIJG-UHFFFAOYSA-N 6-(4-fluorophenyl)-8-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C=12N3CCNC(=O)C3=CC2=CC(C)=CC=1C1=CC=C(F)C=C1 YPDUMRZFRFBIJG-UHFFFAOYSA-N 0.000 claims description 2
- LQLBCGSAPSVEGN-UHFFFAOYSA-N 6-(4-methylsulfonylphenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2 LQLBCGSAPSVEGN-UHFFFAOYSA-N 0.000 claims description 2
- MLXDPGXBWQRYII-UHFFFAOYSA-N 6-(4-tert-butylphenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=CC(C(C)(C)C)=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2 MLXDPGXBWQRYII-UHFFFAOYSA-N 0.000 claims description 2
- XFFQTVWJMUMMPB-UHFFFAOYSA-N 6-(4-tert-butylphenyl)-8-fluoro-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound C(C)(C)(C)C1=CC=C(C=C1)C1=CC(=CC=2C(=C3N(C12)CCNC3=O)C)F XFFQTVWJMUMMPB-UHFFFAOYSA-N 0.000 claims description 2
- HACRIFDZAIGULO-UHFFFAOYSA-N 6-(5-chlorothiophen-2-yl)-8-fluoro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(Cl)S1 HACRIFDZAIGULO-UHFFFAOYSA-N 0.000 claims description 2
- JXGNWCYWBAADLL-UHFFFAOYSA-N 6-(6-aminopyridin-3-yl)-8-chloro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(Cl)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(N)N=C1 JXGNWCYWBAADLL-UHFFFAOYSA-N 0.000 claims description 2
- IQSZSMBEWQIWII-UHFFFAOYSA-N 6-(6-aminopyridin-3-yl)-8-fluoro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(N)N=C1 IQSZSMBEWQIWII-UHFFFAOYSA-N 0.000 claims description 2
- RZCIRLUORSAYHV-UHFFFAOYSA-N 6-(6-chloropyridin-3-yl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=NC(Cl)=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2 RZCIRLUORSAYHV-UHFFFAOYSA-N 0.000 claims description 2
- NDSBXKCUGZDAPY-UHFFFAOYSA-N 6-(6-chloropyridin-3-yl)-8-fluoro-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC1=CC=C(C=N1)C1=CC(=CC=2C(=C3N(C12)CCNC3=O)C)F NDSBXKCUGZDAPY-UHFFFAOYSA-N 0.000 claims description 2
- RWCHNCCFTCEBPI-UHFFFAOYSA-N 6-(6-fluoropyridin-3-yl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=NC(F)=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2 RWCHNCCFTCEBPI-UHFFFAOYSA-N 0.000 claims description 2
- QRNHJJKJORJUOW-UHFFFAOYSA-N 6-[4-(hydroxymethyl)phenyl]-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(CO)C=C1 QRNHJJKJORJUOW-UHFFFAOYSA-N 0.000 claims description 2
- ZNWYSKTVMOWFRB-UHFFFAOYSA-N 6-[4-chloro-3-(trifluoromethyl)phenyl]-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(Cl)C(C(F)(F)F)=C1 ZNWYSKTVMOWFRB-UHFFFAOYSA-N 0.000 claims description 2
- GFIDBENVBHEFPS-UHFFFAOYSA-N 6-[4-chloro-3-(trifluoromethyl)phenyl]-8-fluoro-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC1=C(C=C(C=C1)C1=CC(=CC=2C(=C3N(C12)CCNC3=O)C)F)C(F)(F)F GFIDBENVBHEFPS-UHFFFAOYSA-N 0.000 claims description 2
- LOVSLZYHKRJRNM-UHFFFAOYSA-N 6-[6-(dimethylamino)pyridin-3-yl]-8-fluoro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=NC(N(C)C)=CC=C1C1=CC(F)=CC2=C1N1CCNC(=O)C1=C2C LOVSLZYHKRJRNM-UHFFFAOYSA-N 0.000 claims description 2
- FQYRERHBGYJMKF-UHFFFAOYSA-N 7-(2,4-dichlorophenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound ClC1=CC(Cl)=CC=C1C1=CC(C#N)=CC2=C1N1CCCNC(=O)C1=C2 FQYRERHBGYJMKF-UHFFFAOYSA-N 0.000 claims description 2
- RBSHSDVFURCGTL-UHFFFAOYSA-N 7-(2-chloropyridin-4-yl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=NC(Cl)=CC(C=2C=3N4CCCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 RBSHSDVFURCGTL-UHFFFAOYSA-N 0.000 claims description 2
- ZBGNHOCTFFTVBI-UHFFFAOYSA-N 7-(2-fluoropyridin-4-yl)-11-methyl-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CC=NC(F)=C1 ZBGNHOCTFFTVBI-UHFFFAOYSA-N 0.000 claims description 2
- XRZHHDYHGIHKDO-UHFFFAOYSA-N 7-(3,4-difluorophenyl)-11-methyl-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CC=C(F)C(F)=C1 XRZHHDYHGIHKDO-UHFFFAOYSA-N 0.000 claims description 2
- WLHFFAFSSRPJDB-UHFFFAOYSA-N 7-(3,4-difluorophenyl)-9-fluoro-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C=12N3CCCNC(=O)C3=CC2=CC(F)=CC=1C1=CC=C(F)C(F)=C1 WLHFFAFSSRPJDB-UHFFFAOYSA-N 0.000 claims description 2
- WRCGWCDEBQEKNA-UHFFFAOYSA-N 7-(3-cyanophenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound O=C1NCCCN(C=23)C1=CC3=CC(C#N)=CC=2C1=CC=CC(C#N)=C1 WRCGWCDEBQEKNA-UHFFFAOYSA-N 0.000 claims description 2
- MVAKRNJMRZKAEG-UHFFFAOYSA-N 7-(3-fluoro-4-methylphenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound Cc1ccc(cc1F)-c1cc(cc2cc3C(=O)NCCCn3c12)C#N MVAKRNJMRZKAEG-UHFFFAOYSA-N 0.000 claims description 2
- ZNJVUUKFSOHZPU-UHFFFAOYSA-N 7-(4-chloro-3-fluorophenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(Cl)C(F)=CC(C=2C=3N4CCCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 ZNJVUUKFSOHZPU-UHFFFAOYSA-N 0.000 claims description 2
- ZLQNDSHNCCLRRX-UHFFFAOYSA-N 7-(4-chlorophenyl)-8,9-difluoro-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound FC=1C(F)=CC=2C=C3C(=O)NCCCN3C=2C=1C1=CC=C(Cl)C=C1 ZLQNDSHNCCLRRX-UHFFFAOYSA-N 0.000 claims description 2
- HLAATUXXNOEZCX-UHFFFAOYSA-N 7-(4-chlorophenyl)-9-fluoro-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C=12N3CCCNC(=O)C3=CC2=CC(F)=CC=1C1=CC=C(Cl)C=C1 HLAATUXXNOEZCX-UHFFFAOYSA-N 0.000 claims description 2
- HAVJURIFBWGADI-UHFFFAOYSA-N 7-(4-chlorophenyl)-9-methyl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C=12N3CCCNC(=O)C3=CC2=CC(C)=CC=1C1=CC=C(Cl)C=C1 HAVJURIFBWGADI-UHFFFAOYSA-N 0.000 claims description 2
- SOMFYZKYWFFGMA-UHFFFAOYSA-N 7-(4-fluorophenyl)-9-methyl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C=12N3CCCNC(=O)C3=CC2=CC(C)=CC=1C1=CC=C(F)C=C1 SOMFYZKYWFFGMA-UHFFFAOYSA-N 0.000 claims description 2
- SSMDEKJINYXZHJ-UHFFFAOYSA-N 7-(4-methoxyphenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=CC(OC)=CC=C1C1=CC(C#N)=CC2=C1N1CCCNC(=O)C1=C2 SSMDEKJINYXZHJ-UHFFFAOYSA-N 0.000 claims description 2
- SMKJKSVVHCSURO-UHFFFAOYSA-N 7-(4-nitrophenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=CC([N+](=O)[O-])=CC=C1C1=CC(C#N)=CC2=C1N1CCCNC(=O)C1=C2 SMKJKSVVHCSURO-UHFFFAOYSA-N 0.000 claims description 2
- XDHIYWHOSCQRHH-UHFFFAOYSA-N 7-(6-aminopyridin-3-yl)-11-methyl-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CC=C(N)N=C1 XDHIYWHOSCQRHH-UHFFFAOYSA-N 0.000 claims description 2
- KLCFAZGFUDBGPE-UHFFFAOYSA-N 7-(6-fluoropyridin-3-yl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=NC(F)=CC=C1C1=CC(C#N)=CC2=C1N1CCCNC(=O)C1=C2 KLCFAZGFUDBGPE-UHFFFAOYSA-N 0.000 claims description 2
- RDVYONFKQSBGFP-UHFFFAOYSA-N 7-(6-fluoropyridin-3-yl)-11-methyl-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CC=C(F)N=C1 RDVYONFKQSBGFP-UHFFFAOYSA-N 0.000 claims description 2
- PPMZJSUHNJVNPQ-UHFFFAOYSA-N 8-chloro-10-methyl-6-(4-methylsulfonylphenyl)-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC1=CC=2C(=C3N(C2C(=C1)C1=CC=C(C=C1)S(=O)(=O)C)CCNC3=O)C PPMZJSUHNJVNPQ-UHFFFAOYSA-N 0.000 claims description 2
- YGNVWEQHXFZSCY-UHFFFAOYSA-N 8-chloro-10-methyl-6-(4-propan-2-ylphenyl)-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC1=CC=2C(=C3N(C2C(=C1)C1=CC=C(C=C1)C(C)C)CCNC3=O)C YGNVWEQHXFZSCY-UHFFFAOYSA-N 0.000 claims description 2
- GMBSYVVTBLPLSE-UHFFFAOYSA-N 8-chloro-10-methyl-6-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC1=CC=2C(=C3N(C2C(=C1)C1=CC=C(C=C1)OC(F)(F)F)CCNC3=O)C GMBSYVVTBLPLSE-UHFFFAOYSA-N 0.000 claims description 2
- QOXOBJTZHKBMTI-UHFFFAOYSA-N 8-chloro-10-methyl-6-[4-(trifluoromethyl)phenyl]-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(Cl)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(C(F)(F)F)C=C1 QOXOBJTZHKBMTI-UHFFFAOYSA-N 0.000 claims description 2
- CEHFBUYXNVBLBO-UHFFFAOYSA-N 8-chloro-10-methyl-6-pyridin-3-yl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC1=CC=2C(=C3N(C2C(=C1)C=1C=NC=CC1)CCNC3=O)C CEHFBUYXNVBLBO-UHFFFAOYSA-N 0.000 claims description 2
- OGSICXGETCNBCQ-UHFFFAOYSA-N 8-chloro-6-(2,3-dihydro-1-benzofuran-5-yl)-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C2OCCC2=CC(C2=C3N4CCNC(=O)C4=C(C3=CC(Cl)=C2)C)=C1 OGSICXGETCNBCQ-UHFFFAOYSA-N 0.000 claims description 2
- HGTGBYDNSOEXLM-UHFFFAOYSA-N 8-chloro-6-(2,4-dichlorophenyl)-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(Cl)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(Cl)C=C1Cl HGTGBYDNSOEXLM-UHFFFAOYSA-N 0.000 claims description 2
- JAGLZVPFGHXZDS-UHFFFAOYSA-N 8-chloro-6-(2,4-difluorophenyl)-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC1=CC=2C(=C3N(C2C(=C1)C1=C(C=C(C=C1)F)F)CCNC3=O)C JAGLZVPFGHXZDS-UHFFFAOYSA-N 0.000 claims description 2
- BBIQWHIDVGJPSU-UHFFFAOYSA-N 8-chloro-6-(2-chloropyridin-4-yl)-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC1=CC=2C(=C3N(C2C(=C1)C1=CC(=NC=C1)Cl)CCNC3=O)C BBIQWHIDVGJPSU-UHFFFAOYSA-N 0.000 claims description 2
- WXBLFVPHCNYNEI-UHFFFAOYSA-N 8-chloro-6-(3,4-difluorophenyl)-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C(F)=CC=C1C1=CC(Cl)=CC2=C1N1CCNC(=O)C1=C2 WXBLFVPHCNYNEI-UHFFFAOYSA-N 0.000 claims description 2
- QAINMJIAOWDPAQ-UHFFFAOYSA-N 8-chloro-6-(3,5-difluorophenyl)-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC1=CC=2C(=C3N(C2C(=C1)C1=CC(=CC(=C1)F)F)CCNC3=O)C QAINMJIAOWDPAQ-UHFFFAOYSA-N 0.000 claims description 2
- ZCTWMWAUFDYWFL-UHFFFAOYSA-N 8-chloro-6-(3-chlorophenyl)-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(Cl)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=CC(Cl)=C1 ZCTWMWAUFDYWFL-UHFFFAOYSA-N 0.000 claims description 2
- KNFUXVLKEYSCKM-UHFFFAOYSA-N 8-chloro-6-(3-fluorophenyl)-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(Cl)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=CC(F)=C1 KNFUXVLKEYSCKM-UHFFFAOYSA-N 0.000 claims description 2
- RUXFXEUSHYGDCM-UHFFFAOYSA-N 8-chloro-6-(4-chloro-2-fluorophenyl)-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC1=CC=2C(=C3N(C2C(=C1)C1=C(C=C(C=C1)Cl)F)CCNC3=O)C RUXFXEUSHYGDCM-UHFFFAOYSA-N 0.000 claims description 2
- JIBHWAPFXFANTQ-UHFFFAOYSA-N 8-chloro-6-(4-chloro-3-fluorophenyl)-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC1=CC=2C(=C3N(C2C(=C1)C1=CC(=C(C=C1)Cl)F)CCNC3=O)C JIBHWAPFXFANTQ-UHFFFAOYSA-N 0.000 claims description 2
- ZFPCAAUIDMACKC-UHFFFAOYSA-N 8-chloro-6-(4-chlorophenyl)-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(Cl)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(Cl)C=C1 ZFPCAAUIDMACKC-UHFFFAOYSA-N 0.000 claims description 2
- LBKBWRHWAQXOMK-UHFFFAOYSA-N 8-chloro-6-(4-fluorophenyl)-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(Cl)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(F)C=C1 LBKBWRHWAQXOMK-UHFFFAOYSA-N 0.000 claims description 2
- ZWOYLIWNJNCMOW-UHFFFAOYSA-N 8-chloro-6-(4-fluorophenyl)-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=CC(F)=CC=C1C1=CC(Cl)=CC2=C1N1CCNC(=O)C1=C2 ZWOYLIWNJNCMOW-UHFFFAOYSA-N 0.000 claims description 2
- RCNQWYSSCUFYPV-UHFFFAOYSA-N 8-chloro-6-(4-methoxyphenyl)-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=CC(OC)=CC=C1C1=CC(Cl)=CC2=C1N1CCNC(=O)C1=C2 RCNQWYSSCUFYPV-UHFFFAOYSA-N 0.000 claims description 2
- DNMPCDRDZOJESM-UHFFFAOYSA-N 8-chloro-6-(6-chloropyridin-3-yl)-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC1=CC=2C(=C3N(C2C(=C1)C=1C=NC(=CC1)Cl)CCNC3=O)C DNMPCDRDZOJESM-UHFFFAOYSA-N 0.000 claims description 2
- WSZMESIPNSQJLP-UHFFFAOYSA-N 8-chloro-6-(6-fluoropyridin-3-yl)-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC1=CC=2C(=C3N(C2C(=C1)C=1C=NC(=CC1)F)CCNC3=O)C WSZMESIPNSQJLP-UHFFFAOYSA-N 0.000 claims description 2
- OGHXUUPQEZVZRD-UHFFFAOYSA-N 8-chloro-6-(6-methoxypyridin-3-yl)-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC1=CC=2C(=C3N(C2C(=C1)C=1C=NC(=CC1)OC)CCNC3=O)C OGHXUUPQEZVZRD-UHFFFAOYSA-N 0.000 claims description 2
- HDVVOSCNQSPAIH-UHFFFAOYSA-N 8-chloro-6-[4-(dimethylamino)phenyl]-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=CC(N(C)C)=CC=C1C1=CC(Cl)=CC2=C1N1CCNC(=O)C1=C2C HDVVOSCNQSPAIH-UHFFFAOYSA-N 0.000 claims description 2
- UINHJRBVGOCBAP-UHFFFAOYSA-N 8-chloro-6-[4-chloro-3-(trifluoromethyl)phenyl]-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC1=CC=2C(=C3N(C2C(=C1)C1=CC(=C(C=C1)Cl)C(F)(F)F)CCNC3=O)C UINHJRBVGOCBAP-UHFFFAOYSA-N 0.000 claims description 2
- AOJHTWAYYRYWKN-UHFFFAOYSA-N 8-chloro-6-[6-(dimethylamino)pyridin-3-yl]-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=NC(N(C)C)=CC=C1C1=CC(Cl)=CC2=C1N1CCNC(=O)C1=C2C AOJHTWAYYRYWKN-UHFFFAOYSA-N 0.000 claims description 2
- PJZRBZFZJMMTPX-UHFFFAOYSA-N 8-fluoro-10-methyl-6-(2,3,4-trifluorophenyl)-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound FC1=CC=2C(=C3N(C2C(=C1)C1=C(C(=C(C=C1)F)F)F)CCNC3=O)C PJZRBZFZJMMTPX-UHFFFAOYSA-N 0.000 claims description 2
- SXZPWJLSMHNCFQ-UHFFFAOYSA-N 8-fluoro-10-methyl-6-(4-methylsulfonylphenyl)-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(S(C)(=O)=O)C=C1 SXZPWJLSMHNCFQ-UHFFFAOYSA-N 0.000 claims description 2
- ZTYDMBPFBGQVPK-UHFFFAOYSA-N 8-fluoro-10-methyl-6-(4-nitrophenyl)-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C([N+]([O-])=O)C=C1 ZTYDMBPFBGQVPK-UHFFFAOYSA-N 0.000 claims description 2
- XPNVRNWQWKUWLL-UHFFFAOYSA-N 8-fluoro-10-methyl-6-(4-propan-2-ylphenyl)-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=CC(C(C)C)=CC=C1C1=CC(F)=CC2=C1N1CCNC(=O)C1=C2C XPNVRNWQWKUWLL-UHFFFAOYSA-N 0.000 claims description 2
- LAJUJHCHDKCXIP-UHFFFAOYSA-N 8-fluoro-10-methyl-6-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound FC1=CC=2C(=C3N(C2C(=C1)C1=CC=C(C=C1)OC(F)(F)F)CCNC3=O)C LAJUJHCHDKCXIP-UHFFFAOYSA-N 0.000 claims description 2
- ZARIJQBMWRUFFB-UHFFFAOYSA-N 8-fluoro-10-methyl-6-[4-(trifluoromethyl)phenyl]-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound Cc1c2C(=O)NCCn2c2c(cc(F)cc12)-c1ccc(cc1)C(F)(F)F ZARIJQBMWRUFFB-UHFFFAOYSA-N 0.000 claims description 2
- URFNETONPNSDDT-UHFFFAOYSA-N 8-fluoro-10-methyl-6-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=NN=C(C(F)(F)F)S1 URFNETONPNSDDT-UHFFFAOYSA-N 0.000 claims description 2
- ILNZRJGOQYJYKL-UHFFFAOYSA-N 8-fluoro-10-methyl-6-[5-(trifluoromethyl)-1,3-thiazol-2-yl]-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=NC=C(C(F)(F)F)S1 ILNZRJGOQYJYKL-UHFFFAOYSA-N 0.000 claims description 2
- ZHCFJYBQEFDVRB-UHFFFAOYSA-N 8-fluoro-10-methyl-6-phenyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound FC1=CC=2C(=C3N(C2C(=C1)C1=CC=CC=C1)CCNC3=O)C ZHCFJYBQEFDVRB-UHFFFAOYSA-N 0.000 claims description 2
- KXBLNAPNKSRSEL-UHFFFAOYSA-N 8-fluoro-10-methyl-6-pyridin-3-yl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound FC1=CC=2C(=C3N(C2C(=C1)C=1C=NC=CC1)CCNC3=O)C KXBLNAPNKSRSEL-UHFFFAOYSA-N 0.000 claims description 2
- ZPDKEZSZKLSZIA-UHFFFAOYSA-N 8-fluoro-10-methyl-6-pyridin-4-yl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=NC=C1 ZPDKEZSZKLSZIA-UHFFFAOYSA-N 0.000 claims description 2
- WNKYICQPDJAYIU-UHFFFAOYSA-N 8-fluoro-6-(2-fluoropyridin-4-yl)-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound FC1=CC=2C(=C3N(C2C(=C1)C1=CC(=NC=C1)F)CCNC3=O)C WNKYICQPDJAYIU-UHFFFAOYSA-N 0.000 claims description 2
- ICGVSKZFISYGPE-UHFFFAOYSA-N 8-fluoro-6-(3-fluoro-4-methylphenyl)-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound FC1=CC=2C(=C3N(C2C(=C1)C1=CC(=C(C=C1)C)F)CCNC3=O)C ICGVSKZFISYGPE-UHFFFAOYSA-N 0.000 claims description 2
- GWSPDGYSZGWIRO-UHFFFAOYSA-N 8-fluoro-6-(4-fluoro-3-methylphenyl)-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound FC1=CC=2C(=C3N(C2C(=C1)C1=CC(=C(C=C1)F)C)CCNC3=O)C GWSPDGYSZGWIRO-UHFFFAOYSA-N 0.000 claims description 2
- LMGTTWDIKXXUGU-UHFFFAOYSA-N 8-fluoro-6-(4-fluorophenyl)-10-(trifluoromethyl)-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=CC(F)=CC=C1C1=CC(F)=CC2=C1N1CCNC(=O)C1=C2C(F)(F)F LMGTTWDIKXXUGU-UHFFFAOYSA-N 0.000 claims description 2
- NDXQVAGMBWPNJO-UHFFFAOYSA-N 8-fluoro-6-(4-methoxyphenyl)-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=CC(OC)=CC=C1C1=CC(F)=CC2=C1N1CCNC(=O)C1=C2 NDXQVAGMBWPNJO-UHFFFAOYSA-N 0.000 claims description 2
- JGAYXVBGAZWKIC-UHFFFAOYSA-N 8-fluoro-6-(6-fluoropyridin-3-yl)-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound FC1=CC=2C(=C3N(C2C(=C1)C=1C=NC(=CC1)F)CCNC3=O)C JGAYXVBGAZWKIC-UHFFFAOYSA-N 0.000 claims description 2
- MHHXTWXWDPRZSV-UHFFFAOYSA-N 8-fluoro-6-(6-methoxypyridin-3-yl)-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound FC1=CC=2C(=C3N(C2C(=C1)C=1C=NC(=CC1)OC)CCNC3=O)C MHHXTWXWDPRZSV-UHFFFAOYSA-N 0.000 claims description 2
- KIBQYSLTXBVHLY-UHFFFAOYSA-N 8-fluoro-6-(furan-2-yl)-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=CO1 KIBQYSLTXBVHLY-UHFFFAOYSA-N 0.000 claims description 2
- SHIWOWNMYKKGPT-UHFFFAOYSA-N 8-fluoro-6-[4-(hydroxymethyl)phenyl]-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(CO)C=C1 SHIWOWNMYKKGPT-UHFFFAOYSA-N 0.000 claims description 2
- SYAHXLLFAVCMQL-UHFFFAOYSA-N 8-fluoro-6-pyridin-4-yl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C=12N3CCNC(=O)C3=CC2=CC(F)=CC=1C1=CC=NC=C1 SYAHXLLFAVCMQL-UHFFFAOYSA-N 0.000 claims description 2
- ZHNBANMPWMNWMN-UHFFFAOYSA-N 8-methoxy-6-[4-(trifluoromethyl)phenyl]-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C=12N3CCNC(=O)C3=CC2=CC(OC)=CC=1C1=CC=C(C(F)(F)F)C=C1 ZHNBANMPWMNWMN-UHFFFAOYSA-N 0.000 claims description 2
- QSCKNBLVCUOCSO-UHFFFAOYSA-N 9-chloro-7-(4-chlorophenyl)-11-methyl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound Cc1c2C(=O)NCCCn2c2c(cc(Cl)cc12)-c1ccc(Cl)cc1 QSCKNBLVCUOCSO-UHFFFAOYSA-N 0.000 claims description 2
- PKTBBMWXZQESDI-UHFFFAOYSA-N 9-chloro-7-(4-chlorophenyl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1=CC(Cl)=CC=C1C1=CC(Cl)=CC2=C1N1CCCNC(=O)C1=C2 PKTBBMWXZQESDI-UHFFFAOYSA-N 0.000 claims description 2
- PSWSFJFYRMLXSJ-UHFFFAOYSA-N 9-chloro-7-(4-fluorophenyl)-11-methyl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound Cc1c2C(=O)NCCCn2c2c(cc(Cl)cc12)-c1ccc(F)cc1 PSWSFJFYRMLXSJ-UHFFFAOYSA-N 0.000 claims description 2
- GCGHBWLXVMJSAJ-UHFFFAOYSA-N 9-chloro-7-(4-fluorophenyl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1=CC(F)=CC=C1C1=CC(Cl)=CC2=C1N1CCCNC(=O)C1=C2 GCGHBWLXVMJSAJ-UHFFFAOYSA-N 0.000 claims description 2
- CGIVOCXPIUPKJR-UHFFFAOYSA-N 9-fluoro-7-(4-fluorophenyl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1=CC(F)=CC=C1C1=CC(F)=CC2=C1N1CCCNC(=O)C1=C2 CGIVOCXPIUPKJR-UHFFFAOYSA-N 0.000 claims description 2
- RBAQHCZJBNQDKT-UHFFFAOYSA-N 9-fluoro-7-(4-methoxyphenyl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1=CC(OC)=CC=C1C1=CC(F)=CC2=C1N1CCCNC(=O)C1=C2 RBAQHCZJBNQDKT-UHFFFAOYSA-N 0.000 claims description 2
- MCZVQWNQXVAFGO-UHFFFAOYSA-N 9-fluoro-7-(4-methylphenyl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1=CC(C)=CC=C1C1=CC(F)=CC2=C1N1CCCNC(=O)C1=C2 MCZVQWNQXVAFGO-UHFFFAOYSA-N 0.000 claims description 2
- 208000029028 brain injury Diseases 0.000 claims description 2
- 230000004064 dysfunction Effects 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- GZZIUCGTGWTXLY-UHFFFAOYSA-N 1-oxo-6-(2,3,4-trifluorophenyl)-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound FC1=C(F)C(F)=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2 GZZIUCGTGWTXLY-UHFFFAOYSA-N 0.000 claims 1
- VHFAYGXKWKULON-UHFFFAOYSA-N 1-oxo-6-phenyl-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound O=C1NCCN(C=23)C1=CC3=CC(C#N)=CC=2C1=CC=CC=C1 VHFAYGXKWKULON-UHFFFAOYSA-N 0.000 claims 1
- KXJUIVHQAPYLJN-UHFFFAOYSA-N 1-oxo-6-pyrimidin-5-yl-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound O=C1NCCN(C=23)C1=CC3=CC(C#N)=CC=2C1=CN=CN=C1 KXJUIVHQAPYLJN-UHFFFAOYSA-N 0.000 claims 1
- CVKBRTIKRUHHBC-UHFFFAOYSA-N 6-(2-aminopyrimidin-5-yl)-8-chloro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one;8-fluoro-10-methyl-6-pyrimidin-5-yl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CN=CN=C1.C1=C(Cl)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CN=C(N)N=C1 CVKBRTIKRUHHBC-UHFFFAOYSA-N 0.000 claims 1
- FJVMYUVTVDPCPV-UHFFFAOYSA-N 6-(2-chloropyridin-4-yl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile;1-oxo-6-pyridin-3-yl-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound O=C1NCCN(C=23)C1=CC3=CC(C#N)=CC=2C1=CC=CN=C1.C1=NC(Cl)=CC(C=2C=3N4CCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 FJVMYUVTVDPCPV-UHFFFAOYSA-N 0.000 claims 1
- YXNXNLYMRPOWIS-UHFFFAOYSA-N 6-(3,4-dichlorophenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile;6-(3,5-difluorophenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(Cl)C(Cl)=C1.C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC(F)=CC(F)=C1 YXNXNLYMRPOWIS-UHFFFAOYSA-N 0.000 claims 1
- YIDMPSDOUXSHCI-UHFFFAOYSA-N 6-(3,5-dichlorophenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile;10-methyl-6-(4-methylsulfonylphenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC(Cl)=CC(Cl)=C1.C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(S(C)(=O)=O)C=C1 YIDMPSDOUXSHCI-UHFFFAOYSA-N 0.000 claims 1
- VEBIUKMXGWZNQK-UHFFFAOYSA-N 6-(4-fluoro-3-methylphenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile;6-(4-nitrophenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(F)C(C)=CC(C=2C=3N4CCNC(=O)C4=CC=3C=C(C=2)C#N)=C1.C1=CC([N+](=O)[O-])=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2 VEBIUKMXGWZNQK-UHFFFAOYSA-N 0.000 claims 1
- MHJJCMWMWJAGEF-UHFFFAOYSA-N 6-(4-methoxyphenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile;1-oxo-7-(3,4,5-trifluorophenyl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=CC(OC)=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2C.FC1=C(F)C(F)=CC(C=2C=3N4CCCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 MHJJCMWMWJAGEF-UHFFFAOYSA-N 0.000 claims 1
- NZWNURHJFZXDNA-UHFFFAOYSA-N 6-(4-methylphenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=CC(C)=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2 NZWNURHJFZXDNA-UHFFFAOYSA-N 0.000 claims 1
- NMHYMSWYYARDMY-UHFFFAOYSA-N 6-[4-(hydroxymethyl)phenyl]-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=CC(CO)=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2 NMHYMSWYYARDMY-UHFFFAOYSA-N 0.000 claims 1
- KOIUURSSKXHUGD-UHFFFAOYSA-N 6-[4-chloro-3-(trifluoromethyl)phenyl]-1-oxo-3,4-dihydro-2H-pyrazino[1,2-a]indole-8-carbonitrile 7-(2,4-difluorophenyl)-11-methyl-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC=2C(=C3N(C12)CCCNC3=O)C)C#N.ClC3=C(C=C(C=C3)C3=CC(=CC=1C=C2N(C31)CCNC2=O)C#N)C(F)(F)F KOIUURSSKXHUGD-UHFFFAOYSA-N 0.000 claims 1
- LYMZILPSHWXKKM-UHFFFAOYSA-N 7-(3,4-difluorophenyl)-9-methyl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one;7-(4-methoxyphenyl)-9-methyl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1=CC(OC)=CC=C1C1=CC(C)=CC2=C1N1CCCNC(=O)C1=C2.C=12N3CCCNC(=O)C3=CC2=CC(C)=CC=1C1=CC=C(F)C(F)=C1 LYMZILPSHWXKKM-UHFFFAOYSA-N 0.000 claims 1
- WOKPYCFPKWDUAE-UHFFFAOYSA-N 7-(3,5-dichlorophenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile;7-(4-methylphenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=CC(C)=CC=C1C1=CC(C#N)=CC2=C1N1CCCNC(=O)C1=C2.ClC1=CC(Cl)=CC(C=2C=3N4CCCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 WOKPYCFPKWDUAE-UHFFFAOYSA-N 0.000 claims 1
- KTZIKJCEWLQCHY-UHFFFAOYSA-N 7-(3,5-difluorophenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile;7-(3-fluorophenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound FC1=CC=CC(C=2C=3N4CCCNC(=O)C4=CC=3C=C(C=2)C#N)=C1.FC1=CC(F)=CC(C=2C=3N4CCCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 KTZIKJCEWLQCHY-UHFFFAOYSA-N 0.000 claims 1
- VYTIURRJWYRNMP-UHFFFAOYSA-N 7-(4-fluorophenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile 8-(trifluoromethoxy)-6-[4-(trifluoromethyl)phenyl]-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound FC(OC1=CC=2C=C3N(C2C(=C1)C1=CC=C(C=C1)C(F)(F)F)CCNC3=O)(F)F.FC3=CC=C(C=C3)C3=CC(=CC=1C=C2N(C31)CCCNC2=O)C#N VYTIURRJWYRNMP-UHFFFAOYSA-N 0.000 claims 1
- RCWPZLVYSMXFNY-UHFFFAOYSA-N 9-fluoro-7-[4-(trifluoromethyl)phenyl]-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C=12N3CCCNC(=O)C3=CC2=CC(F)=CC=1C1=CC=C(C(F)(F)F)C=C1 RCWPZLVYSMXFNY-UHFFFAOYSA-N 0.000 claims 1
- 206010003805 Autism Diseases 0.000 claims 1
- 208000020706 Autistic disease Diseases 0.000 claims 1
- BSIQJLAJGOJGIY-UHFFFAOYSA-N O=C1NCCN2C1=CC=1C=C(C=C(C21)C2=CC(=C(C(=C2)F)F)F)C#N.ClC2=CC=1C(=C3N(C1C(=C2)C2=CC=C(C=C2)Cl)CCNC3=O)C(F)(F)F Chemical compound O=C1NCCN2C1=CC=1C=C(C=C(C21)C2=CC(=C(C(=C2)F)F)F)C#N.ClC2=CC=1C(=C3N(C1C(=C2)C2=CC=C(C=C2)Cl)CCNC3=O)C(F)(F)F BSIQJLAJGOJGIY-UHFFFAOYSA-N 0.000 claims 1
- 241000124033 Salix Species 0.000 claims 1
- 238000001228 spectrum Methods 0.000 claims 1
- 210000000278 spinal cord Anatomy 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract description 5
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract description 2
- 208000027104 Chemotherapy-Related Cognitive Impairment Diseases 0.000 abstract 1
- 208000028173 post-traumatic stress disease Diseases 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 description 359
- 239000002244 precipitate Substances 0.000 description 356
- 238000007429 general method Methods 0.000 description 347
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 57
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 51
- UMFQTJZWIQXGEU-UHFFFAOYSA-N 6-bromo-8-fluoro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C12=C(Br)C=C(F)C=C2C(C)=C2N1CCNC2=O UMFQTJZWIQXGEU-UHFFFAOYSA-N 0.000 description 45
- NVKINXAUSNGUGY-UHFFFAOYSA-N 6-bromo-8-chloro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C12=C(Br)C=C(Cl)C=C2C(C)=C2N1CCNC2=O NVKINXAUSNGUGY-UHFFFAOYSA-N 0.000 description 43
- KVIOIFKWKBDGAV-UHFFFAOYSA-N 58881-41-7 Chemical compound C1=CC=C2N3C(=O)C4=CC5=CC=CC=C5N4C(=O)C3=CC2=C1 KVIOIFKWKBDGAV-UHFFFAOYSA-N 0.000 description 39
- UTSWVDWUMYKXLC-UHFFFAOYSA-N 6-bromo-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C12=C(Br)C=C(C#N)C=C2C(C)=C2N1CCNC2=O UTSWVDWUMYKXLC-UHFFFAOYSA-N 0.000 description 37
- HRECVVHMLSUUNA-UHFFFAOYSA-N 7-bromo-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C2C(=O)NCCCN2C2=C1C=C(C#N)C=C2Br HRECVVHMLSUUNA-UHFFFAOYSA-N 0.000 description 36
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 36
- WFTIQTCEJBQZKU-UHFFFAOYSA-N 6-bromo-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C2C(=O)NCCN2C2=C1C=C(C#N)C=C2Br WFTIQTCEJBQZKU-UHFFFAOYSA-N 0.000 description 33
- 229910052799 carbon Inorganic materials 0.000 description 29
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 27
- KMVQJSLJJQGEHL-UHFFFAOYSA-N 7-bromo-11-methyl-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound O=C1NCCCN2C3=C(Br)C=C(C#N)C=C3C(C)=C21 KMVQJSLJJQGEHL-UHFFFAOYSA-N 0.000 description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 24
- 239000000243 solution Substances 0.000 description 23
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 22
- LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 22
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 21
- CAYQIZIAYYNFCS-UHFFFAOYSA-N (4-chlorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C=C1 CAYQIZIAYYNFCS-UHFFFAOYSA-N 0.000 description 20
- LBUNNMJLXWQQBY-UHFFFAOYSA-N 4-fluorophenylboronic acid Chemical compound OB(O)C1=CC=C(F)C=C1 LBUNNMJLXWQQBY-UHFFFAOYSA-N 0.000 description 20
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 20
- VOAAEKKFGLPLLU-UHFFFAOYSA-N (4-methoxyphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C=C1 VOAAEKKFGLPLLU-UHFFFAOYSA-N 0.000 description 19
- AQEFLFZSWDEAIP-UHFFFAOYSA-N di-tert-butyl ether Chemical compound CC(C)(C)OC(C)(C)C AQEFLFZSWDEAIP-UHFFFAOYSA-N 0.000 description 19
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 19
- 239000011541 reaction mixture Substances 0.000 description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 17
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 15
- 238000003756 stirring Methods 0.000 description 15
- RMGYQBHKEWWTOY-UHFFFAOYSA-N (3,4-difluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(F)C(F)=C1 RMGYQBHKEWWTOY-UHFFFAOYSA-N 0.000 description 14
- WAXJARYQFLMNEX-UHFFFAOYSA-N 2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=CC=C2C=C3C(=O)NC=CN3C2=C1 WAXJARYQFLMNEX-UHFFFAOYSA-N 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- 238000003818 flash chromatography Methods 0.000 description 13
- 239000000741 silica gel Substances 0.000 description 13
- 229910002027 silica gel Inorganic materials 0.000 description 13
- ALJRPIAYJALVFG-UHFFFAOYSA-N tert-butyl 2,2-dioxooxathiazolidine-3-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCOS1(=O)=O ALJRPIAYJALVFG-UHFFFAOYSA-N 0.000 description 13
- 239000012267 brine Substances 0.000 description 12
- 239000003921 oil Substances 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- 239000012044 organic layer Substances 0.000 description 12
- KLVLZTZWYLTKLF-UHFFFAOYSA-N pyrazino[1,2-a]indole-8-carbonitrile Chemical compound N#Cc1ccc2c(cc3cnccn23)c1 KLVLZTZWYLTKLF-UHFFFAOYSA-N 0.000 description 12
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 12
- 239000012043 crude product Substances 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 10
- QLULGIRFKAWHOJ-UHFFFAOYSA-N pyridin-4-ylboronic acid Chemical compound OB(O)C1=CC=NC=C1 QLULGIRFKAWHOJ-UHFFFAOYSA-N 0.000 description 10
- BIWQNIMLAISTBV-UHFFFAOYSA-N (4-methylphenyl)boronic acid Chemical compound CC1=CC=C(B(O)O)C=C1 BIWQNIMLAISTBV-UHFFFAOYSA-N 0.000 description 9
- DVOVBQCLDPKYFH-UHFFFAOYSA-N 7-bromo-9-fluoro-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1CCNC(=O)C2=CC3=CC(F)=CC(Br)=C3N21 DVOVBQCLDPKYFH-UHFFFAOYSA-N 0.000 description 9
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- SGNPIGAGPRLGEJ-UHFFFAOYSA-N oxathiazolidine-3-carboxylic acid Chemical compound OC(=O)N1CCOS1 SGNPIGAGPRLGEJ-UHFFFAOYSA-N 0.000 description 9
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 8
- KNXQDJCZSVHEIW-UHFFFAOYSA-N (3-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(F)=C1 KNXQDJCZSVHEIW-UHFFFAOYSA-N 0.000 description 7
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 7
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 description 7
- ZFFOBTFXVCCAPE-UHFFFAOYSA-N 6-bromo-8-fluoro-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1CNC(=O)C2=CC3=CC(F)=CC(Br)=C3N21 ZFFOBTFXVCCAPE-UHFFFAOYSA-N 0.000 description 7
- 239000000969 carrier Substances 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 229940125904 compound 1 Drugs 0.000 description 7
- QQLRSCZSKQTFGY-UHFFFAOYSA-N (2,4-difluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(F)C=C1F QQLRSCZSKQTFGY-UHFFFAOYSA-N 0.000 description 6
- WXGBZJJAGLSBPR-UHFFFAOYSA-N (2-fluoropyridin-4-yl)boronic acid Chemical compound OB(O)C1=CC=NC(F)=C1 WXGBZJJAGLSBPR-UHFFFAOYSA-N 0.000 description 6
- QWQBQRYFWNIDOC-UHFFFAOYSA-N (3,5-difluorophenyl)boronic acid Chemical compound OB(O)C1=CC(F)=CC(F)=C1 QWQBQRYFWNIDOC-UHFFFAOYSA-N 0.000 description 6
- WPVBHUUZDFUIJA-UHFFFAOYSA-N (3-fluoro-4-methylphenyl)boronic acid Chemical compound CC1=CC=C(B(O)O)C=C1F WPVBHUUZDFUIJA-UHFFFAOYSA-N 0.000 description 6
- CEBAHYWORUOILU-UHFFFAOYSA-N (4-cyanophenyl)boronic acid Chemical class OB(O)C1=CC=C(C#N)C=C1 CEBAHYWORUOILU-UHFFFAOYSA-N 0.000 description 6
- OJBYZWHAPXIJID-UHFFFAOYSA-N (6-fluoropyridin-3-yl)boronic acid Chemical compound OB(O)C1=CC=C(F)N=C1 OJBYZWHAPXIJID-UHFFFAOYSA-N 0.000 description 6
- HTFXWAOSQODIBI-UHFFFAOYSA-N 2-benzyl-1,3-dihydropyrrolo[3,4-c]pyridine Chemical compound C1C2=CC=NC=C2CN1CC1=CC=CC=C1 HTFXWAOSQODIBI-UHFFFAOYSA-N 0.000 description 6
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 6
- YFTAUNOLAHRUIE-UHFFFAOYSA-N 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=C(N)N=C1 YFTAUNOLAHRUIE-UHFFFAOYSA-N 0.000 description 6
- RVFDZUDWFJUAFI-UHFFFAOYSA-N 7-bromo-9-chloro-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1CCNC(=O)C2=CC3=CC(Cl)=CC(Br)=C3N21 RVFDZUDWFJUAFI-UHFFFAOYSA-N 0.000 description 6
- JUUQZTHRRUWHIG-UHFFFAOYSA-N 8-fluoro-10-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1B1OC(C)(C)C(C)(C)O1 JUUQZTHRRUWHIG-UHFFFAOYSA-N 0.000 description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- HUOFUOCSQCYFPW-UHFFFAOYSA-N [4-(trifluoromethoxy)phenyl]boronic acid Chemical compound OB(O)C1=CC=C(OC(F)(F)F)C=C1 HUOFUOCSQCYFPW-UHFFFAOYSA-N 0.000 description 6
- 239000000460 chlorine Substances 0.000 description 6
- 229910052801 chlorine Inorganic materials 0.000 description 6
- ZAUJOWOCPLOJNM-UHFFFAOYSA-N ethyl 7-bromo-5-fluoro-1h-indole-2-carboxylate Chemical compound FC1=CC(Br)=C2NC(C(=O)OCC)=CC2=C1 ZAUJOWOCPLOJNM-UHFFFAOYSA-N 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000011259 mixed solution Substances 0.000 description 6
- 210000002569 neuron Anatomy 0.000 description 6
- ABMYEXAYWZJVOV-UHFFFAOYSA-N pyridin-3-ylboronic acid Chemical class OB(O)C1=CC=CN=C1 ABMYEXAYWZJVOV-UHFFFAOYSA-N 0.000 description 6
- HZFPPBMKGYINDF-UHFFFAOYSA-N pyrimidin-5-ylboronic acid Chemical compound OB(O)C1=CN=CN=C1 HZFPPBMKGYINDF-UHFFFAOYSA-N 0.000 description 6
- CLGIPVVEERQWSQ-UHFFFAOYSA-N (2,3,4-trifluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(F)C(F)=C1F CLGIPVVEERQWSQ-UHFFFAOYSA-N 0.000 description 5
- QNEGDGPAXKYZHZ-UHFFFAOYSA-N (2,4-dichlorophenyl)boronic acid Chemical class OB(O)C1=CC=C(Cl)C=C1Cl QNEGDGPAXKYZHZ-UHFFFAOYSA-N 0.000 description 5
- WJYRVVDXJMJLTN-UHFFFAOYSA-N (2-chloropyridin-4-yl)boronic acid Chemical compound OB(O)C1=CC=NC(Cl)=C1 WJYRVVDXJMJLTN-UHFFFAOYSA-N 0.000 description 5
- UHDDEIOYXFXNNJ-UHFFFAOYSA-N (3,4,5-trifluorophenyl)boronic acid Chemical compound OB(O)C1=CC(F)=C(F)C(F)=C1 UHDDEIOYXFXNNJ-UHFFFAOYSA-N 0.000 description 5
- JKIGHOARKAIPJI-UHFFFAOYSA-N (3,4-dichlorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C(Cl)=C1 JKIGHOARKAIPJI-UHFFFAOYSA-N 0.000 description 5
- XDBHWPLGGBLUHH-UHFFFAOYSA-N (3-cyanophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(C#N)=C1 XDBHWPLGGBLUHH-UHFFFAOYSA-N 0.000 description 5
- YBNDRTRLXPEWKQ-UHFFFAOYSA-N (4-chloro-2-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C=C1F YBNDRTRLXPEWKQ-UHFFFAOYSA-N 0.000 description 5
- JCIJCHSRVPSOML-UHFFFAOYSA-N (4-fluoro-3-methylphenyl)boronic acid Chemical compound CC1=CC(B(O)O)=CC=C1F JCIJCHSRVPSOML-UHFFFAOYSA-N 0.000 description 5
- VDUKDQTYMWUSAC-UHFFFAOYSA-N (4-methylsulfonylphenyl)boronic acid Chemical compound CS(=O)(=O)C1=CC=C(B(O)O)C=C1 VDUKDQTYMWUSAC-UHFFFAOYSA-N 0.000 description 5
- MNJYZNVROSZZQC-UHFFFAOYSA-N (4-tert-butylphenyl)boronic acid Chemical class CC(C)(C)C1=CC=C(B(O)O)C=C1 MNJYZNVROSZZQC-UHFFFAOYSA-N 0.000 description 5
- WPAPNCXMYWRTTL-UHFFFAOYSA-N (6-chloropyridin-3-yl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)N=C1 WPAPNCXMYWRTTL-UHFFFAOYSA-N 0.000 description 5
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 description 5
- 125000004361 3,4,5-trifluorophenyl group Chemical group [H]C1=C(F)C(F)=C(F)C([H])=C1* 0.000 description 5
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 5
- CTSGIQYYVIRANE-UHFFFAOYSA-N 6-bromo-7,8-difluoro-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C2C(=O)NCCN2C2=C1C=C(F)C(F)=C2Br CTSGIQYYVIRANE-UHFFFAOYSA-N 0.000 description 5
- FMBRXAQTKHCOSO-UHFFFAOYSA-N 6-bromo-8,9-difluoro-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1CNC(=O)C2=CC3=C(F)C(F)=CC(Br)=C3N21 FMBRXAQTKHCOSO-UHFFFAOYSA-N 0.000 description 5
- GCPOBLVYFKKZKJ-UHFFFAOYSA-N 6-bromo-8-methoxy-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1CNC(=O)C2=CC3=CC(OC)=CC(Br)=C3N21 GCPOBLVYFKKZKJ-UHFFFAOYSA-N 0.000 description 5
- FDQIJJCAZPRACL-UHFFFAOYSA-N 7-bromo-8,9-difluoro-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1=C2C(=O)NCCCN2C2=C1C=C(F)C(F)=C2Br FDQIJJCAZPRACL-UHFFFAOYSA-N 0.000 description 5
- BIOKRWXPIZSWOJ-UHFFFAOYSA-N 7-bromo-9-chloro-11-methyl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound O=C1NCCCN2C3=C(Br)C=C(Cl)C=C3C(C)=C21 BIOKRWXPIZSWOJ-UHFFFAOYSA-N 0.000 description 5
- ZDKWZBFTUMQRHT-UHFFFAOYSA-N 7-bromo-9-methyl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1CCNC(=O)C2=CC3=CC(C)=CC(Br)=C3N21 ZDKWZBFTUMQRHT-UHFFFAOYSA-N 0.000 description 5
- PZRPBPMLSSNFOM-UHFFFAOYSA-N [4-(hydroxymethyl)phenyl]boronic acid Chemical class OCC1=CC=C(B(O)O)C=C1 PZRPBPMLSSNFOM-UHFFFAOYSA-N 0.000 description 5
- ALMFIOZYDASRRC-UHFFFAOYSA-N [4-(trifluoromethyl)phenyl]boronic acid Chemical class OB(O)C1=CC=C(C(F)(F)F)C=C1 ALMFIOZYDASRRC-UHFFFAOYSA-N 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 5
- 238000001665 trituration Methods 0.000 description 5
- CMJQIHGBUKZEHP-UHFFFAOYSA-N (4-chloro-3-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C(F)=C1 CMJQIHGBUKZEHP-UHFFFAOYSA-N 0.000 description 4
- WIKBZUXHNPONPP-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoro-2-iodo-2-(trifluoromethyl)propane Chemical compound FC(F)(F)C(I)(C(F)(F)F)C(F)(F)F WIKBZUXHNPONPP-UHFFFAOYSA-N 0.000 description 4
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 4
- 125000004863 4-trifluoromethoxyphenyl group Chemical group [H]C1=C([H])C(OC(F)(F)F)=C([H])C([H])=C1* 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- 229910017976 MgO 4 Inorganic materials 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000006143 cell culture medium Substances 0.000 description 4
- 230000001149 cognitive effect Effects 0.000 description 4
- 230000002996 emotional effect Effects 0.000 description 4
- VABKCLOAFMABBV-UHFFFAOYSA-N ethyl 7-bromo-5-chloro-1h-indole-2-carboxylate Chemical compound ClC1=CC(Br)=C2NC(C(=O)OCC)=CC2=C1 VABKCLOAFMABBV-UHFFFAOYSA-N 0.000 description 4
- 125000000716 hydrazinylidene group Chemical group [*]=NN([H])[H] 0.000 description 4
- 125000005638 hydrazono group Chemical group 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- WYVFFWMPUOYDJH-UHFFFAOYSA-N methyl 7-bromo-5-chloro-3-methyl-1h-indole-2-carboxylate Chemical compound C1=C(Cl)C=C2C(C)=C(C(=O)OC)NC2=C1Br WYVFFWMPUOYDJH-UHFFFAOYSA-N 0.000 description 4
- 230000001272 neurogenic effect Effects 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 210000000130 stem cell Anatomy 0.000 description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- 125000003944 tolyl group Chemical group 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- 125000004360 trifluorophenyl group Chemical group 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- IHQARZFHEULYEH-UHFFFAOYSA-N (2-bromo-3,4-difluorophenyl)hydrazine Chemical compound NNC1=CC=C(F)C(F)=C1Br IHQARZFHEULYEH-UHFFFAOYSA-N 0.000 description 3
- SDEAGACSNFSZCU-UHFFFAOYSA-N (3-chlorophenyl)boronic acid Chemical class OB(O)C1=CC=CC(Cl)=C1 SDEAGACSNFSZCU-UHFFFAOYSA-N 0.000 description 3
- FPTATZYBAJMHAW-UHFFFAOYSA-N 1-oxo-7-pyrimidin-5-yl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound O=C1NCCCN(C=23)C1=CC3=CC(C#N)=CC=2C1=CN=CN=C1 FPTATZYBAJMHAW-UHFFFAOYSA-N 0.000 description 3
- LQCJQOPLZCBEIC-UHFFFAOYSA-N 6-bromo-8-chloro-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1CNC(=O)C2=CC3=CC(Cl)=CC(Br)=C3N21 LQCJQOPLZCBEIC-UHFFFAOYSA-N 0.000 description 3
- UXDQTVAKNOYGOX-UHFFFAOYSA-N 7-(4-methylphenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=CC(C)=CC=C1C1=CC(C#N)=CC2=C1N1CCCNC(=O)C1=C2 UXDQTVAKNOYGOX-UHFFFAOYSA-N 0.000 description 3
- ICNUXKBINASLLO-UHFFFAOYSA-N 7-bromo-9,10-difluoro-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1CCNC(=O)C2=CC3=C(F)C(F)=CC(Br)=C3N21 ICNUXKBINASLLO-UHFFFAOYSA-N 0.000 description 3
- CTWVBVPDRHCUSJ-UHFFFAOYSA-N 8-fluoro-6-(4-methoxyphenyl)-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=CC(OC)=CC=C1C1=CC(F)=CC2=C1N1CCNC(=O)C1=C2C CTWVBVPDRHCUSJ-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- OPOJUAFTEGDKHY-UHFFFAOYSA-N ethyl 7-bromo-5,6-difluoro-1h-indole-2-carboxylate Chemical compound FC1=C(F)C(Br)=C2NC(C(=O)OCC)=CC2=C1 OPOJUAFTEGDKHY-UHFFFAOYSA-N 0.000 description 3
- DYIFCUFDYHGQAX-UHFFFAOYSA-N ethyl 7-bromo-5-methyl-1h-indole-2-carboxylate Chemical compound CC1=CC(Br)=C2NC(C(=O)OCC)=CC2=C1 DYIFCUFDYHGQAX-UHFFFAOYSA-N 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229940098779 methanesulfonic acid Drugs 0.000 description 3
- NWGWOHJVAVJAEE-UHFFFAOYSA-N methyl 7-bromo-5-cyano-3-methyl-1h-indole-2-carboxylate Chemical compound C1=C(C#N)C=C2C(C)=C(C(=O)OC)NC2=C1Br NWGWOHJVAVJAEE-UHFFFAOYSA-N 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- CGHYQZASLKERLV-UHFFFAOYSA-N (2-aminopyrimidin-5-yl)boronic acid Chemical compound NC1=NC=C(B(O)O)C=N1 CGHYQZASLKERLV-UHFFFAOYSA-N 0.000 description 2
- KLTYFJSQVYXJBX-UHFFFAOYSA-N (2-bromo-4,5-difluorophenyl)hydrazine Chemical compound NNC1=CC(F)=C(F)C=C1Br KLTYFJSQVYXJBX-UHFFFAOYSA-N 0.000 description 2
- OJMHGYZZACDGPA-UHFFFAOYSA-N (2-bromo-4-chlorophenyl)hydrazine Chemical compound NNC1=CC=C(Cl)C=C1Br OJMHGYZZACDGPA-UHFFFAOYSA-N 0.000 description 2
- MDBQIXTUWHFITK-UHFFFAOYSA-N (2-bromo-4-cyano-6-iodophenyl)carbamic acid Chemical compound OC(=O)Nc1c(Br)cc(cc1I)C#N MDBQIXTUWHFITK-UHFFFAOYSA-N 0.000 description 2
- RJJQYRJBFRVSEQ-UHFFFAOYSA-N (2-bromo-4-fluorophenyl)hydrazine Chemical compound NNC1=CC=C(F)C=C1Br RJJQYRJBFRVSEQ-UHFFFAOYSA-N 0.000 description 2
- IBMHCNBKNJHIFH-UHFFFAOYSA-N (2-bromo-4-methoxyphenyl)hydrazine Chemical compound COC1=CC=C(NN)C(Br)=C1 IBMHCNBKNJHIFH-UHFFFAOYSA-N 0.000 description 2
- YPWAJLGHACDYQS-UHFFFAOYSA-N (2-methoxypyrimidin-5-yl)boronic acid Chemical compound COC1=NC=C(B(O)O)C=N1 YPWAJLGHACDYQS-UHFFFAOYSA-N 0.000 description 2
- DKYRKAIKWFHQHM-UHFFFAOYSA-N (3,5-dichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=CC(Cl)=C1 DKYRKAIKWFHQHM-UHFFFAOYSA-N 0.000 description 2
- IAEUFBDMVKQCLU-UHFFFAOYSA-N (4-propan-2-ylphenyl)boronic acid Chemical class CC(C)C1=CC=C(B(O)O)C=C1 IAEUFBDMVKQCLU-UHFFFAOYSA-N 0.000 description 2
- XYSUZDIQSVQNGI-UHFFFAOYSA-N 1,2,3,4-tetrahydropyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1NCCN2C1=CC=1C=C(C=CC21)C#N XYSUZDIQSVQNGI-UHFFFAOYSA-N 0.000 description 2
- CKIDZFDJJHOQAL-UHFFFAOYSA-N 1,3-dioxol-4-ylboronic acid Chemical compound OB(O)C1=COCO1 CKIDZFDJJHOQAL-UHFFFAOYSA-N 0.000 description 2
- TUZKYXYHZDWVNU-UHFFFAOYSA-N 11-methyl-1-oxo-7-pyridin-3-yl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CC=CN=C1 TUZKYXYHZDWVNU-UHFFFAOYSA-N 0.000 description 2
- QKBHNYNTGLBOJA-UHFFFAOYSA-N 11-methyl-1-oxo-7-pyrimidin-5-yl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CN=CN=C1 QKBHNYNTGLBOJA-UHFFFAOYSA-N 0.000 description 2
- ZIXLJHSFAMVHPC-UHFFFAOYSA-N 2,3-dihydro-1-benzofuran-5-ylboronic acid Chemical compound OB(O)C1=CC=C2OCCC2=C1 ZIXLJHSFAMVHPC-UHFFFAOYSA-N 0.000 description 2
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 2
- GIJISQUAMZVXQE-UHFFFAOYSA-N 3-bromo-4-hydrazinylbenzonitrile Chemical compound NNC1=CC=C(C#N)C=C1Br GIJISQUAMZVXQE-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 description 2
- 125000004861 4-isopropyl phenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- XTRIIJNJDIUDRK-UHFFFAOYSA-N 6-(2-aminopyrimidin-5-yl)-8-chloro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(Cl)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CN=C(N)N=C1 XTRIIJNJDIUDRK-UHFFFAOYSA-N 0.000 description 2
- CRZRTBDOLMEYIT-UHFFFAOYSA-N 6-(3,4-dichlorophenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(Cl)C(Cl)=C1 CRZRTBDOLMEYIT-UHFFFAOYSA-N 0.000 description 2
- SEEADYNBHFCZHO-UHFFFAOYSA-N 6-(3,5-dichlorophenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC(Cl)=CC(Cl)=C1 SEEADYNBHFCZHO-UHFFFAOYSA-N 0.000 description 2
- DRICTVIAMIAFFG-UHFFFAOYSA-N 6-(4-methoxyphenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=CC(OC)=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2C DRICTVIAMIAFFG-UHFFFAOYSA-N 0.000 description 2
- ISGXZLKTLYDDGT-UHFFFAOYSA-N 6-bromo-8-(trifluoromethoxy)-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1CNC(=O)C2=CC3=CC(OC(F)(F)F)=CC(Br)=C3N21 ISGXZLKTLYDDGT-UHFFFAOYSA-N 0.000 description 2
- RMDNKHORGAQLHY-UHFFFAOYSA-N 6-bromo-8-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1CNC(=O)C2=CC3=CC(C)=CC(Br)=C3N21 RMDNKHORGAQLHY-UHFFFAOYSA-N 0.000 description 2
- SBGVWJAMFHYWOR-UHFFFAOYSA-N 7-(2,4-difluorophenyl)-11-methyl-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCCN3C2=C1C1=CC=C(F)C=C1F SBGVWJAMFHYWOR-UHFFFAOYSA-N 0.000 description 2
- SKMVQMXGSOJXJA-UHFFFAOYSA-N 7-(3,4-difluorophenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1=C(F)C(F)=CC=C1C1=CC(C#N)=CC2=C1N1CCCNC(=O)C1=C2 SKMVQMXGSOJXJA-UHFFFAOYSA-N 0.000 description 2
- MSUAZUURTFANDH-UHFFFAOYSA-N 7-(3,4-difluorophenyl)-9-methyl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C=12N3CCCNC(=O)C3=CC2=CC(C)=CC=1C1=CC=C(F)C(F)=C1 MSUAZUURTFANDH-UHFFFAOYSA-N 0.000 description 2
- IBDWWUHPKACXEC-UHFFFAOYSA-N 7-(3,5-difluorophenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound FC1=CC(F)=CC(C=2C=3N4CCCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 IBDWWUHPKACXEC-UHFFFAOYSA-N 0.000 description 2
- KHKJDNOACFYSIZ-UHFFFAOYSA-N 7-bromo-2-formyl-1h-indole-5-carbonitrile Chemical compound BrC1=CC(C#N)=CC2=C1NC(C=O)=C2 KHKJDNOACFYSIZ-UHFFFAOYSA-N 0.000 description 2
- FBWQDZICYVUDFY-UHFFFAOYSA-N 8,9-difluoro-7-(4-methoxyphenyl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1=CC(OC)=CC=C1C1=C(F)C(F)=CC2=C1N1CCCNC(=O)C1=C2 FBWQDZICYVUDFY-UHFFFAOYSA-N 0.000 description 2
- AMRHZLPPACDOAK-UHFFFAOYSA-N 8-chloro-6-(4-chlorophenyl)-10-(trifluoromethyl)-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound FC(F)(F)c1c2C(=O)NCCn2c2c(cc(Cl)cc12)-c1ccc(Cl)cc1 AMRHZLPPACDOAK-UHFFFAOYSA-N 0.000 description 2
- MSGBYHKUGCMSPL-UHFFFAOYSA-N 8-fluoro-10-methyl-6-pyrimidin-5-yl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CN=CN=C1 MSGBYHKUGCMSPL-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- FIVBALVUOUHOEA-UHFFFAOYSA-N BrC=1C=C(C=C2C=C(N(C12)C(=O)O)C(OCC)OCC)C#N Chemical compound BrC=1C=C(C=C2C=C(N(C12)C(=O)O)C(OCC)OCC)C#N FIVBALVUOUHOEA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 2
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 2
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 2
- 239000001828 Gelatine Substances 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 239000005089 Luciferase Substances 0.000 description 2
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- RIIPFHVHLXPMHQ-UHFFFAOYSA-N [4-(dimethylamino)phenyl]boronic acid Chemical compound CN(C)C1=CC=C(B(O)O)C=C1 RIIPFHVHLXPMHQ-UHFFFAOYSA-N 0.000 description 2
- XHKNQBNGLMOTDB-UHFFFAOYSA-N [4-chloro-3-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=C(Cl)C(C(F)(F)F)=C1 XHKNQBNGLMOTDB-UHFFFAOYSA-N 0.000 description 2
- NIDRXNINGRRBFV-UHFFFAOYSA-N [6-(dimethylamino)pyridin-3-yl]boronic acid Chemical compound CN(C)C1=CC=C(B(O)O)C=N1 NIDRXNINGRRBFV-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000935 antidepressant agent Substances 0.000 description 2
- 229940005513 antidepressants Drugs 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 125000005605 benzo group Chemical group 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000013256 coordination polymer Substances 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- DEZRYPDIMOWBDS-UHFFFAOYSA-N dcm dichloromethane Chemical compound ClCCl.ClCCl DEZRYPDIMOWBDS-UHFFFAOYSA-N 0.000 description 2
- 210000001947 dentate gyrus Anatomy 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- VQGZMCUHJVVWNX-UHFFFAOYSA-N ethyl 7-bromo-4,5-difluoro-1-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]indole-2-carboxylate Chemical compound FC1=CC(Br)=C2N(CCNC(=O)OC(C)(C)C)C(C(=O)OCC)=CC2=C1F VQGZMCUHJVVWNX-UHFFFAOYSA-N 0.000 description 2
- RNNIRULVVNTQPS-UHFFFAOYSA-N ethyl 7-bromo-4,5-difluoro-1-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propyl]indole-2-carboxylate Chemical compound FC1=CC(Br)=C2N(CCCNC(=O)OC(C)(C)C)C(C(=O)OCC)=CC2=C1F RNNIRULVVNTQPS-UHFFFAOYSA-N 0.000 description 2
- WBEUAKFKMYOBFF-UHFFFAOYSA-N ethyl 7-bromo-4,5-difluoro-1h-indole-2-carboxylate Chemical compound FC1=CC(Br)=C2NC(C(=O)OCC)=CC2=C1F WBEUAKFKMYOBFF-UHFFFAOYSA-N 0.000 description 2
- HNOORLCBYGZAPM-UHFFFAOYSA-N ethyl 7-bromo-5,6-difluoro-1-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]indole-2-carboxylate Chemical compound FC1=C(F)C(Br)=C2N(CCNC(=O)OC(C)(C)C)C(C(=O)OCC)=CC2=C1 HNOORLCBYGZAPM-UHFFFAOYSA-N 0.000 description 2
- RYEZMULIPMQXSN-UHFFFAOYSA-N ethyl 7-bromo-5-chloro-1-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]indole-2-carboxylate Chemical compound ClC1=CC(Br)=C2N(CCNC(=O)OC(C)(C)C)C(C(=O)OCC)=CC2=C1 RYEZMULIPMQXSN-UHFFFAOYSA-N 0.000 description 2
- BKSIEDPMDCLZPB-UHFFFAOYSA-N ethyl 7-bromo-5-chloro-1-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propyl]indole-2-carboxylate Chemical compound ClC1=CC(Br)=C2N(CCCNC(=O)OC(C)(C)C)C(C(=O)OCC)=CC2=C1 BKSIEDPMDCLZPB-UHFFFAOYSA-N 0.000 description 2
- HZUNZDWKYUVOBH-UHFFFAOYSA-N ethyl 7-bromo-5-chloro-3-methyl-1-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]indole-2-carboxylate Chemical compound ClC1=CC(Br)=C2N(CCNC(=O)OC(C)(C)C)C(C(=O)OCC)=C(C)C2=C1 HZUNZDWKYUVOBH-UHFFFAOYSA-N 0.000 description 2
- BIKVZAMUHUGCRE-UHFFFAOYSA-N ethyl 7-bromo-5-cyano-3-methyl-1-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]indole-2-carboxylate Chemical compound N#CC1=CC(Br)=C2N(CCNC(=O)OC(C)(C)C)C(C(=O)OCC)=C(C)C2=C1 BIKVZAMUHUGCRE-UHFFFAOYSA-N 0.000 description 2
- IQSLNAOBRYBRAT-UHFFFAOYSA-N ethyl 7-bromo-5-fluoro-1-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propyl]indole-2-carboxylate Chemical compound FC1=CC(Br)=C2N(CCCNC(=O)OC(C)(C)C)C(C(=O)OCC)=CC2=C1 IQSLNAOBRYBRAT-UHFFFAOYSA-N 0.000 description 2
- CTZVDUSSBCUMLA-UHFFFAOYSA-N ethyl 7-bromo-5-fluoro-3-methyl-1-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]indole-2-carboxylate Chemical compound FC1=CC(Br)=C2N(CCNC(=O)OC(C)(C)C)C(C(=O)OCC)=C(C)C2=C1 CTZVDUSSBCUMLA-UHFFFAOYSA-N 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 230000009808 hippocampal neurogenesis Effects 0.000 description 2
- 210000001320 hippocampus Anatomy 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000001153 interneuron Anatomy 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229960001375 lactose Drugs 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- YEWJIMJKIZUAGQ-UHFFFAOYSA-N methyl 7-bromo-5-cyano-1-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]indole-2-carboxylate Chemical compound N#CC1=CC(Br)=C2N(CCNC(=O)OC(C)(C)C)C(C(=O)OC)=CC2=C1 YEWJIMJKIZUAGQ-UHFFFAOYSA-N 0.000 description 2
- OVIJARQHURBSOI-UHFFFAOYSA-N methyl 7-bromo-5-cyano-1h-indole-2-carboxylate Chemical compound N#CC1=CC(Br)=C2NC(C(=O)OC)=CC2=C1 OVIJARQHURBSOI-UHFFFAOYSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 2
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 2
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000010802 sludge Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
- CUPOOAWTRIURFT-UHFFFAOYSA-N thiophene-2-carbonitrile Chemical compound N#CC1=CC=CS1 CUPOOAWTRIURFT-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- DOMQFIFVDIAOOT-ROUUACIJSA-N (2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NN=C1C=1C=NC=C(C=1)C)NS(=O)(=O)[C@@H](C)[C@H](C)C1=NC=C(C=N1)C DOMQFIFVDIAOOT-ROUUACIJSA-N 0.000 description 1
- ITOFPJRDSCGOSA-KZLRUDJFSA-N (2s)-2-[[(4r)-4-[(3r,5r,8r,9s,10s,13r,14s,17r)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H](CC[C@]13C)[C@@H]2[C@@H]3CC[C@@H]1[C@H](C)CCC(=O)N[C@H](C(O)=O)CC1=CNC2=CC=CC=C12 ITOFPJRDSCGOSA-KZLRUDJFSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- NSFJAFZHYOAMHL-UHFFFAOYSA-N (4-nitrophenyl)boronic acid Chemical class OB(O)C1=CC=C([N+]([O-])=O)C=C1 NSFJAFZHYOAMHL-UHFFFAOYSA-N 0.000 description 1
- DHADXDMPEUWEAS-UHFFFAOYSA-N (6-methoxypyridin-3-yl)boronic acid Chemical compound COC1=CC=C(B(O)O)C=N1 DHADXDMPEUWEAS-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UKGJZDSUJSPAJL-YPUOHESYSA-N (e)-n-[(1r)-1-[3,5-difluoro-4-(methanesulfonamido)phenyl]ethyl]-3-[2-propyl-6-(trifluoromethyl)pyridin-3-yl]prop-2-enamide Chemical compound CCCC1=NC(C(F)(F)F)=CC=C1\C=C\C(=O)N[C@H](C)C1=CC(F)=C(NS(C)(=O)=O)C(F)=C1 UKGJZDSUJSPAJL-YPUOHESYSA-N 0.000 description 1
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- NCWDBNBNYVVARF-UHFFFAOYSA-N 1,3,2-dioxaborolane Chemical compound B1OCCO1 NCWDBNBNYVVARF-UHFFFAOYSA-N 0.000 description 1
- 125000004520 1,3,4-thiadiazolyl group Chemical group 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- OLHKQOTVNIMLPV-UHFFFAOYSA-N 1-oxo-6-(3,4,5-trifluorophenyl)-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound FC1=C(F)C(F)=CC(C=2C=3N4CCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 OLHKQOTVNIMLPV-UHFFFAOYSA-N 0.000 description 1
- OCRILLYZXWHOOA-UHFFFAOYSA-N 1-oxo-7-(3,4,5-trifluorophenyl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound FC1=C(F)C(F)=CC(C=2C=3N4CCCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 OCRILLYZXWHOOA-UHFFFAOYSA-N 0.000 description 1
- SRSJQKLGEHJDMJ-UHFFFAOYSA-N 1-oxo-7-pyridin-4-yl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound O=C1NCCCN(C=23)C1=CC3=CC(C#N)=CC=2C1=CC=NC=C1 SRSJQKLGEHJDMJ-UHFFFAOYSA-N 0.000 description 1
- GPFUVYYSCQCOAD-UHFFFAOYSA-N 10-methyl-6-(4-methylsulfonylphenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(S(C)(=O)=O)C=C1 GPFUVYYSCQCOAD-UHFFFAOYSA-N 0.000 description 1
- XLCROOZJLJJPTG-UHFFFAOYSA-N 11-methyl-1-oxo-7-[4-(trifluoromethoxy)phenyl]-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound CC1=C2N(C=3C(=CC(=CC13)C#N)C1=CC=C(C=C1)OC(F)(F)F)CCCNC2=O XLCROOZJLJJPTG-UHFFFAOYSA-N 0.000 description 1
- HCUARRIEZVDMPT-UHFFFAOYSA-M 1h-indole-2-carboxylate Chemical compound C1=CC=C2NC(C(=O)[O-])=CC2=C1 HCUARRIEZVDMPT-UHFFFAOYSA-M 0.000 description 1
- LGDPYLCJCWPBIP-UHFFFAOYSA-N 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound C1NCCCN2C1=CC=1C=C(C=CC21)C#N LGDPYLCJCWPBIP-UHFFFAOYSA-N 0.000 description 1
- XNERZZLXKNMXSX-UHFFFAOYSA-N 2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound O=C1NCCCN2C3=CC=CC=C3C=C12 XNERZZLXKNMXSX-UHFFFAOYSA-N 0.000 description 1
- RXNZFHIEDZEUQM-UHFFFAOYSA-N 2-bromo-1,3-thiazole Chemical compound BrC1=NC=CS1 RXNZFHIEDZEUQM-UHFFFAOYSA-N 0.000 description 1
- ZGZURPPCPVPDMX-UHFFFAOYSA-N 2-bromo-3,4-difluoroaniline Chemical compound NC1=CC=C(F)C(F)=C1Br ZGZURPPCPVPDMX-UHFFFAOYSA-N 0.000 description 1
- BUTIDJREEDINSI-UHFFFAOYSA-N 2-bromo-4,5-difluoroaniline Chemical compound NC1=CC(F)=C(F)C=C1Br BUTIDJREEDINSI-UHFFFAOYSA-N 0.000 description 1
- ROSTYHNIIDIBEG-UHFFFAOYSA-N 2-bromo-4-(trifluoromethoxy)aniline Chemical compound NC1=CC=C(OC(F)(F)F)C=C1Br ROSTYHNIIDIBEG-UHFFFAOYSA-N 0.000 description 1
- SYTBIFURTZACKR-UHFFFAOYSA-N 2-bromo-4-chloroaniline Chemical compound NC1=CC=C(Cl)C=C1Br SYTBIFURTZACKR-UHFFFAOYSA-N 0.000 description 1
- YLMFXCIATJJKQL-UHFFFAOYSA-N 2-bromo-4-fluoroaniline Chemical compound NC1=CC=C(F)C=C1Br YLMFXCIATJJKQL-UHFFFAOYSA-N 0.000 description 1
- YBAGMTVKDRIMTB-UHFFFAOYSA-N 2-bromo-4-methoxyaniline Chemical compound COC1=CC=C(N)C(Br)=C1 YBAGMTVKDRIMTB-UHFFFAOYSA-N 0.000 description 1
- LGTVLLPQCMJOGT-UHFFFAOYSA-N 2-bromo-5-(trifluoromethyl)-1,3,4-thiadiazole Chemical compound FC(F)(F)C1=NN=C(Br)S1 LGTVLLPQCMJOGT-UHFFFAOYSA-N 0.000 description 1
- UFZHUWFGWBQZTL-UHFFFAOYSA-N 2-bromo-5-(trifluoromethyl)-1,3-thiazole Chemical compound FC(F)(F)C1=CN=C(Br)S1 UFZHUWFGWBQZTL-UHFFFAOYSA-N 0.000 description 1
- ZFAJPWYXLYGUJU-UHFFFAOYSA-N 2-bromo-5-chlorothiophene Chemical compound ClC1=CC=C(Br)S1 ZFAJPWYXLYGUJU-UHFFFAOYSA-N 0.000 description 1
- OYMCMWPHMPODNK-UHFFFAOYSA-N 2-bromofuran Chemical compound BrC1=CC=CO1 OYMCMWPHMPODNK-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- BZSVVCFHMVMYCR-UHFFFAOYSA-N 2-pyridin-2-ylpyridine;ruthenium Chemical compound [Ru].N1=CC=CC=C1C1=CC=CC=N1.N1=CC=CC=C1C1=CC=CC=N1.N1=CC=CC=C1C1=CC=CC=N1 BZSVVCFHMVMYCR-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- YGYGASJNJTYNOL-CQSZACIVSA-N 3-[(4r)-2,2-dimethyl-1,1-dioxothian-4-yl]-5-(4-fluorophenyl)-1h-indole-7-carboxamide Chemical compound C1CS(=O)(=O)C(C)(C)C[C@@H]1C1=CNC2=C(C(N)=O)C=C(C=3C=CC(F)=CC=3)C=C12 YGYGASJNJTYNOL-CQSZACIVSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- GJOOCAXPERKNMN-UHFFFAOYSA-N 3-fluoro-4-methylphenol Chemical compound CC1=CC=C(O)C=C1F GJOOCAXPERKNMN-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- VJPPLCNBDLZIFG-ZDUSSCGKSA-N 4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide Chemical compound C(C#CC)(=O)N[C@@H]1CN(CCC1)C1=C2C(=C(NC2=C(C=C1F)C(=O)N)C)C VJPPLCNBDLZIFG-ZDUSSCGKSA-N 0.000 description 1
- YFCIFWOJYYFDQP-PTWZRHHISA-N 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide Chemical compound CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1 YFCIFWOJYYFDQP-PTWZRHHISA-N 0.000 description 1
- XYWIPYBIIRTJMM-IBGZPJMESA-N 4-[[(2S)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide Chemical compound CC[C@H](N1C=C(OC)C(=CC1=O)C1=C(C=CC(Cl)=C1)N1C=C(N=N1)C(F)(F)F)C(=O)NC1=CC(F)=C(C=C1)C(N)=O XYWIPYBIIRTJMM-IBGZPJMESA-N 0.000 description 1
- ZXCXPHSSIDEPDP-UHFFFAOYSA-N 4-amino-3-bromo-5-iodobenzonitrile Chemical compound NC1=C(Br)C=C(C#N)C=C1I ZXCXPHSSIDEPDP-UHFFFAOYSA-N 0.000 description 1
- POESQIHWIIWNJL-UHFFFAOYSA-N 4-amino-3-bromobenzonitrile Chemical compound NC1=CC=C(C#N)C=C1Br POESQIHWIIWNJL-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- YVVHCBNJWHPMCQ-UHFFFAOYSA-N 5-bromothiophene-2-carbonitrile Chemical compound BrC1=CC=C(C#N)S1 YVVHCBNJWHPMCQ-UHFFFAOYSA-N 0.000 description 1
- BZLUUKANDVSSOP-UHFFFAOYSA-N 6-(1,3-benzodioxol-5-yl)-8-chloro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C2OCOC2=CC(C2=C3N4CCNC(=O)C4=C(C3=CC(Cl)=C2)C)=C1 BZLUUKANDVSSOP-UHFFFAOYSA-N 0.000 description 1
- WCTCYYPBXWGWIV-UHFFFAOYSA-N 6-(2-chloropyridin-4-yl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=NC(Cl)=CC(C=2C=3N4CCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 WCTCYYPBXWGWIV-UHFFFAOYSA-N 0.000 description 1
- INVAVUIZTQSUOR-UHFFFAOYSA-N 6-(2-chloropyridin-4-yl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=NC(Cl)=C1 INVAVUIZTQSUOR-UHFFFAOYSA-N 0.000 description 1
- WMUJBLKYAFERIK-UHFFFAOYSA-N 6-(3,5-difluorophenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC(F)=CC(F)=C1 WMUJBLKYAFERIK-UHFFFAOYSA-N 0.000 description 1
- ACABQZSRFQYKEU-UHFFFAOYSA-N 6-(3-fluorophenyl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=CC(F)=C1 ACABQZSRFQYKEU-UHFFFAOYSA-N 0.000 description 1
- JAIWBJYUJOMMKT-UHFFFAOYSA-N 6-(4-chloro-2-fluorophenyl)-8-fluoro-10-methyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(F)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(Cl)C=C1F JAIWBJYUJOMMKT-UHFFFAOYSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- QFKSCUNPBZOMPQ-UHFFFAOYSA-N 6-(4-fluoro-3-methylphenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(F)C(C)=CC(C=2C=3N4CCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 QFKSCUNPBZOMPQ-UHFFFAOYSA-N 0.000 description 1
- SOZUWHSMUJBDIP-UHFFFAOYSA-N 6-(4-nitrophenyl)-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=CC([N+](=O)[O-])=CC=C1C1=CC(C#N)=CC2=C1N1CCNC(=O)C1=C2 SOZUWHSMUJBDIP-UHFFFAOYSA-N 0.000 description 1
- LRQCOOGRQAVODS-UHFFFAOYSA-N 6-(6-aminopyridin-3-yl)-10-methyl-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=C(N)N=C1 LRQCOOGRQAVODS-UHFFFAOYSA-N 0.000 description 1
- RMCCCKAJWHWZKI-UHFFFAOYSA-N 6-[4-chloro-3-(trifluoromethyl)phenyl]-1-oxo-3,4-dihydro-2h-pyrazino[1,2-a]indole-8-carbonitrile Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(C=2C=3N4CCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 RMCCCKAJWHWZKI-UHFFFAOYSA-N 0.000 description 1
- TVEXGJYMHHTVKP-UHFFFAOYSA-N 6-oxabicyclo[3.2.1]oct-3-en-7-one Chemical compound C1C2C(=O)OC1C=CC2 TVEXGJYMHHTVKP-UHFFFAOYSA-N 0.000 description 1
- IQRAGYBNSWPTLI-UHFFFAOYSA-N 7,8-difluoro-6-(4-fluorophenyl)-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=CC(F)=CC=C1C1=C(F)C(F)=CC2=C1N1CCNC(=O)C1=C2 IQRAGYBNSWPTLI-UHFFFAOYSA-N 0.000 description 1
- DMJGDVFSDFBRGO-UHFFFAOYSA-N 7,8-difluoro-6-(4-methoxyphenyl)-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=CC(OC)=CC=C1C1=C(F)C(F)=CC2=C1N1CCNC(=O)C1=C2 DMJGDVFSDFBRGO-UHFFFAOYSA-N 0.000 description 1
- WUSGVDFRXZYGAR-UHFFFAOYSA-N 7-(3,5-dichlorophenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound ClC1=CC(Cl)=CC(C=2C=3N4CCCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 WUSGVDFRXZYGAR-UHFFFAOYSA-N 0.000 description 1
- JTQGDNFHAILFEE-UHFFFAOYSA-N 7-(3-fluorophenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound FC1=CC=CC(C=2C=3N4CCCNC(=O)C4=CC=3C=C(C=2)C#N)=C1 JTQGDNFHAILFEE-UHFFFAOYSA-N 0.000 description 1
- ZJLSGAAXUIFTAD-UHFFFAOYSA-N 7-(4-fluorophenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-9-carbonitrile Chemical compound Fc1ccc(cc1)-c1cc(cc2cc3C(=O)NCCCn3c12)C#N ZJLSGAAXUIFTAD-UHFFFAOYSA-N 0.000 description 1
- IIPMWWJYFQOOJW-UHFFFAOYSA-N 7-(4-methoxyphenyl)-9-methyl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1=CC(OC)=CC=C1C1=CC(C)=CC2=C1N1CCCNC(=O)C1=C2 IIPMWWJYFQOOJW-UHFFFAOYSA-N 0.000 description 1
- UTURXHSETSIIBC-UHFFFAOYSA-N 7-bromo-5-fluoro-1-[4-[(2-methylpropan-2-yl)oxycarbonylamino]butan-2-yl]indole-2-carboxylic acid Chemical compound CC(CCNC(=O)OC(C)(C)C)N1C(=CC2=CC(=CC(=C21)Br)F)C(=O)O UTURXHSETSIIBC-UHFFFAOYSA-N 0.000 description 1
- OEJDSKPNYKSVLQ-UHFFFAOYSA-N 8,9-difluoro-6-(4-fluorophenyl)-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=CC(F)=CC=C1C1=CC(F)=C(F)C2=C1N1CCNC(=O)C1=C2 OEJDSKPNYKSVLQ-UHFFFAOYSA-N 0.000 description 1
- VSZLJTVMCUCGJN-UHFFFAOYSA-N 8,9-difluoro-6-(4-methoxyphenyl)-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=CC(OC)=CC=C1C1=CC(F)=C(F)C2=C1N1CCNC(=O)C1=C2 VSZLJTVMCUCGJN-UHFFFAOYSA-N 0.000 description 1
- QRTKLHGMWSXPEW-UHFFFAOYSA-N 8,9-difluoro-7-(4-fluorophenyl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1=CC(F)=CC=C1C1=C(F)C(F)=CC2=C1N1CCCNC(=O)C1=C2 QRTKLHGMWSXPEW-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- QMQNNCSOXJCXFW-UHFFFAOYSA-N 8-(trifluoromethoxy)-6-[4-(trifluoromethyl)phenyl]-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C=12N3CCNC(=O)C3=CC2=CC(OC(F)(F)F)=CC=1C1=CC=C(C(F)(F)F)C=C1 QMQNNCSOXJCXFW-UHFFFAOYSA-N 0.000 description 1
- SASFFDNFHOGBGS-UHFFFAOYSA-N 8-chloro-10-methyl-6-(2,3,4-trifluorophenyl)-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one Chemical compound ClC1=CC=2C(=C3N(C2C(=C1)C1=C(C(=C(C=C1)F)F)F)CCNC3=O)C SASFFDNFHOGBGS-UHFFFAOYSA-N 0.000 description 1
- NQRANWXFHBSKDY-UHFFFAOYSA-N 8-chloro-10-methyl-6-phenyl-3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Chemical compound C1=C(Cl)C=C2C(C)=C3C(=O)NCCN3C2=C1C1=CC=CC=C1 NQRANWXFHBSKDY-UHFFFAOYSA-N 0.000 description 1
- LWMYRKOSZWVFBS-UHFFFAOYSA-N 9,10-difluoro-7-(4-fluorophenyl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1=CC(F)=CC=C1C1=CC(F)=C(F)C2=C1N1CCCNC(=O)C1=C2 LWMYRKOSZWVFBS-UHFFFAOYSA-N 0.000 description 1
- UHKMUSUUHSTPIK-UHFFFAOYSA-N 9,10-difluoro-7-(4-methoxyphenyl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indol-1-one Chemical compound C1=CC(OC)=CC=C1C1=CC(F)=C(F)C2=C1N1CCCNC(=O)C1=C2 UHKMUSUUHSTPIK-UHFFFAOYSA-N 0.000 description 1
- ZRPZPNYZFSJUPA-UHFFFAOYSA-N ARS-1620 Chemical compound Oc1cccc(F)c1-c1c(Cl)cc2c(ncnc2c1F)N1CCN(CC1)C(=O)C=C ZRPZPNYZFSJUPA-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical group [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- ABCGSOFAAFMGBR-UHFFFAOYSA-N C1CN(C(=O)C2=CC3=CC=CC=C3N21)F Chemical compound C1CN(C(=O)C2=CC3=CC=CC=C3N21)F ABCGSOFAAFMGBR-UHFFFAOYSA-N 0.000 description 1
- 102100032986 CCR4-NOT transcription complex subunit 8 Human genes 0.000 description 1
- ISNFMVCIQIFGGM-UHFFFAOYSA-N CN(CCCN(C1=C2)C(C(C3=CC=CC=C3)=C3)=C2C=C3C#N)C1=O Chemical compound CN(CCCN(C1=C2)C(C(C3=CC=CC=C3)=C3)=C2C=C3C#N)C1=O ISNFMVCIQIFGGM-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- XXRCUYVCPSWGCC-UHFFFAOYSA-N Ethyl pyruvate Chemical compound CCOC(=O)C(C)=O XXRCUYVCPSWGCC-UHFFFAOYSA-N 0.000 description 1
- GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 1
- 102100021337 Gap junction alpha-1 protein Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101000942586 Homo sapiens CCR4-NOT transcription complex subunit 8 Proteins 0.000 description 1
- 101000894966 Homo sapiens Gap junction alpha-1 protein Proteins 0.000 description 1
- 101001094629 Homo sapiens Popeye domain-containing protein 2 Proteins 0.000 description 1
- 101000608230 Homo sapiens Pyrin domain-containing protein 2 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- HCUARRIEZVDMPT-UHFFFAOYSA-N Indole-2-carboxylic acid Chemical class C1=CC=C2NC(C(=O)O)=CC2=C1 HCUARRIEZVDMPT-UHFFFAOYSA-N 0.000 description 1
- LNQCUTNLHUQZLR-VNPYQEQNSA-N Iridin Natural products O(C)c1c(O)c2C(=O)C(c3cc(OC)c(OC)c(O)c3)=COc2cc1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 LNQCUTNLHUQZLR-VNPYQEQNSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- FEYNFHSRETUBEM-UHFFFAOYSA-N N-[3-(1,1-difluoroethyl)phenyl]-1-(4-methoxyphenyl)-3-methyl-5-oxo-4H-pyrazole-4-carboxamide Chemical compound COc1ccc(cc1)N1N=C(C)C(C(=O)Nc2cccc(c2)C(C)(F)F)C1=O FEYNFHSRETUBEM-UHFFFAOYSA-N 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- YODURNSBAMQVAH-UHFFFAOYSA-N O=C1NCCN2C1=CC=1C=C(C=C(C21)C2=CC=C(C=C2)C(F)(F)F)C#N.O=C2NCCN1C2=CC=2C=C(C=C(C12)C1=CC=C(C=C1)C)C#N Chemical compound O=C1NCCN2C1=CC=1C=C(C=C(C21)C2=CC=C(C=C2)C(F)(F)F)C#N.O=C2NCCN1C2=CC=2C=C(C=C(C12)C1=CC=C(C=C1)C)C#N YODURNSBAMQVAH-UHFFFAOYSA-N 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 208000010340 Sleep Deprivation Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 101150046432 Tril gene Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- AJMXKMJDWBEJHS-UHFFFAOYSA-N [2-(6-methoxypyridin-3-yl)phenyl]boronic acid Chemical compound C1=NC(OC)=CC=C1C1=CC=CC=C1B(O)O AJMXKMJDWBEJHS-UHFFFAOYSA-N 0.000 description 1
- LBYIIQUFMSAHEC-UHFFFAOYSA-N [2-bromo-4-(trifluoromethoxy)phenyl]hydrazine Chemical compound NNC1=CC=C(OC(F)(F)F)C=C1Br LBYIIQUFMSAHEC-UHFFFAOYSA-N 0.000 description 1
- WOAORAPRPVIATR-UHFFFAOYSA-N [3-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=CC(C(F)(F)F)=C1 WOAORAPRPVIATR-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229960004977 anhydrous lactose Drugs 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 125000004533 benzofuran-5-yl group Chemical group O1C=CC2=C1C=CC(=C2)* 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- DGLFSNZWRYADFC-UHFFFAOYSA-N chembl2334586 Chemical compound C1CCC2=CN=C(N)N=C2C2=C1NC1=CC=C(C#CC(C)(O)C)C=C12 DGLFSNZWRYADFC-UHFFFAOYSA-N 0.000 description 1
- 229940068911 chloride hexahydrate Drugs 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- XHQZXHMRBXBPEL-UHFFFAOYSA-N eaton reagent Chemical compound CS(O)(=O)=O.O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 XHQZXHMRBXBPEL-UHFFFAOYSA-N 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- CEUGLEGTDXYQJV-UHFFFAOYSA-N ethyl 7-bromo-5,6-difluoro-1-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propyl]indole-2-carboxylate Chemical compound FC1=C(F)C(Br)=C2N(CCCNC(=O)OC(C)(C)C)C(C(=O)OCC)=CC2=C1 CEUGLEGTDXYQJV-UHFFFAOYSA-N 0.000 description 1
- FFYGMDHMTSTALT-UHFFFAOYSA-N ethyl 7-bromo-5-(trifluoromethoxy)-1h-indole-2-carboxylate Chemical compound FC(F)(F)OC1=CC(Br)=C2NC(C(=O)OCC)=CC2=C1 FFYGMDHMTSTALT-UHFFFAOYSA-N 0.000 description 1
- VQFDDTTVAWHXJA-UHFFFAOYSA-N ethyl 7-bromo-5-fluoro-1-[4-[(2-methylpropan-2-yl)oxycarbonylamino]butan-2-yl]indole-2-carboxylate Chemical compound FC1=CC(Br)=C2N(C(C)CCNC(=O)OC(C)(C)C)C(C(=O)OCC)=CC2=C1 VQFDDTTVAWHXJA-UHFFFAOYSA-N 0.000 description 1
- VIEQXCXKUBFEDD-UHFFFAOYSA-N ethyl 7-bromo-5-methoxy-1-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]indole-2-carboxylate Chemical compound COC1=CC(Br)=C2N(CCNC(=O)OC(C)(C)C)C(C(=O)OCC)=CC2=C1 VIEQXCXKUBFEDD-UHFFFAOYSA-N 0.000 description 1
- XMLIRECOIFLVRU-UHFFFAOYSA-N ethyl 7-bromo-5-methoxy-1h-indole-2-carboxylate Chemical compound COC1=CC(Br)=C2NC(C(=O)OCC)=CC2=C1 XMLIRECOIFLVRU-UHFFFAOYSA-N 0.000 description 1
- FZKZTDOACIINKV-UHFFFAOYSA-N ethyl 7-bromo-5-methyl-1-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]indole-2-carboxylate Chemical compound CC1=CC(Br)=C2N(CCNC(=O)OC(C)(C)C)C(C(=O)OCC)=CC2=C1 FZKZTDOACIINKV-UHFFFAOYSA-N 0.000 description 1
- GOPUYCPLHDVPEG-UHFFFAOYSA-N ethyl 7-bromo-5-methyl-1-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propyl]indole-2-carboxylate Chemical compound CC1=CC(Br)=C2N(CCCNC(=O)OC(C)(C)C)C(C(=O)OCC)=CC2=C1 GOPUYCPLHDVPEG-UHFFFAOYSA-N 0.000 description 1
- 229940117360 ethyl pyruvate Drugs 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- LIYGYAHYXQDGEP-UHFFFAOYSA-N firefly oxyluciferin Natural products Oc1csc(n1)-c1nc2ccc(O)cc2s1 LIYGYAHYXQDGEP-UHFFFAOYSA-N 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 229950004696 flusalan Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- VOAPTKOANCCNFV-UHFFFAOYSA-N hexahydrate;hydrochloride Chemical compound O.O.O.O.O.O.Cl VOAPTKOANCCNFV-UHFFFAOYSA-N 0.000 description 1
- 150000002429 hydrazines Chemical class 0.000 description 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 108010047623 iridine Proteins 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 210000003140 lateral ventricle Anatomy 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- XPIWVCAMONZQCP-UHFFFAOYSA-N methyl 2-oxobutanoate Chemical compound CCC(=O)C(=O)OC XPIWVCAMONZQCP-UHFFFAOYSA-N 0.000 description 1
- UFKBIAWWIJJNOP-UHFFFAOYSA-N methyl 7-bromo-5-chloro-3-methyl-1-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propyl]indole-2-carboxylate Chemical compound ClC1=CC(Br)=C2N(CCCNC(=O)OC(C)(C)C)C(C(=O)OC)=C(C)C2=C1 UFKBIAWWIJJNOP-UHFFFAOYSA-N 0.000 description 1
- RLFYSFRBLUQPIU-UHFFFAOYSA-N methyl 7-bromo-5-cyano-1-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propyl]indole-2-carboxylate Chemical compound N#CC1=CC(Br)=C2N(CCCNC(=O)OC(C)(C)C)C(C(=O)OC)=CC2=C1 RLFYSFRBLUQPIU-UHFFFAOYSA-N 0.000 description 1
- QWGIZCBNPMPMAX-UHFFFAOYSA-N methyl 7-bromo-5-fluoro-3-methyl-1h-indole-2-carboxylate Chemical compound C1=C(F)C=C2C(C)=C(C(=O)OC)NC2=C1Br QWGIZCBNPMPMAX-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- FMASTMURQSHELY-UHFFFAOYSA-N n-(4-fluoro-2-methylphenyl)-3-methyl-n-[(2-methyl-1h-indol-4-yl)methyl]pyridine-4-carboxamide Chemical compound C1=CC=C2NC(C)=CC2=C1CN(C=1C(=CC(F)=CC=1)C)C(=O)C1=CC=NC=C1C FMASTMURQSHELY-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- NNKPHNTWNILINE-UHFFFAOYSA-N n-cyclopropyl-3-fluoro-4-methyl-5-[3-[[1-[2-[2-(methylamino)ethoxy]phenyl]cyclopropyl]amino]-2-oxopyrazin-1-yl]benzamide Chemical compound CNCCOC1=CC=CC=C1C1(NC=2C(N(C=3C(=C(F)C=C(C=3)C(=O)NC3CC3)C)C=CN=2)=O)CC1 NNKPHNTWNILINE-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000000626 neurodegenerative effect Effects 0.000 description 1
- 230000007265 neurogenic response Effects 0.000 description 1
- 230000003018 neuroregenerative effect Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 210000000956 olfactory bulb Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- RWEBPCTYBHXFPA-UHFFFAOYSA-N oxathiazinane-3-carboxylic acid Chemical compound OC(=O)N1CCCOS1 RWEBPCTYBHXFPA-UHFFFAOYSA-N 0.000 description 1
- JJVOROULKOMTKG-UHFFFAOYSA-N oxidized Photinus luciferin Chemical compound S1C2=CC(O)=CC=C2N=C1C1=NC(=O)CS1 JJVOROULKOMTKG-UHFFFAOYSA-N 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- QJPQVXSHYBGQGM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 QJPQVXSHYBGQGM-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920002714 polyornithine Polymers 0.000 description 1
- 108010055896 polyornithine Proteins 0.000 description 1
- LZMJNVRJMFMYQS-UHFFFAOYSA-N poseltinib Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(OC=2C=C(NC(=O)C=C)C=CC=2)=C(OC=C2)C2=N1 LZMJNVRJMFMYQS-UHFFFAOYSA-N 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000015284 positive regulation of neurogenesis Effects 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004262 preparative liquid chromatography Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- GCZDLZHMAMLSJF-UHFFFAOYSA-N pyrazino[1,2-a]indole Chemical compound C1=CN=CC2=CC3=CC=CC=C3N21 GCZDLZHMAMLSJF-UHFFFAOYSA-N 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- VPAYJEUHKVESSD-UHFFFAOYSA-N trifluoroiodomethane Chemical compound FC(F)(F)I VPAYJEUHKVESSD-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12179381 | 2012-08-06 | ||
| PCT/EP2013/066344 WO2014023674A1 (en) | 2012-08-06 | 2013-08-05 | Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-1-one |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201590125A1 EA201590125A1 (ru) | 2015-05-29 |
| EA025884B1 true EA025884B1 (ru) | 2017-02-28 |
Family
ID=48918402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201590125A EA025884B1 (ru) | 2012-08-06 | 2013-08-05 | ПИПЕРАЗИНО[1,2-a]ИНДОЛ-1-ОНЫ И [1,4]ДИАЗЕПИНО[1,2-a]ИНДОЛ-1-ОН |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US9284321B2 (enExample) |
| EP (1) | EP2880036B1 (enExample) |
| JP (1) | JP5974177B2 (enExample) |
| KR (1) | KR101716062B1 (enExample) |
| CN (1) | CN104540829B (enExample) |
| AR (1) | AR092041A1 (enExample) |
| AU (1) | AU2013301577B2 (enExample) |
| BR (1) | BR112015000313A2 (enExample) |
| CA (1) | CA2880682A1 (enExample) |
| CL (1) | CL2015000143A1 (enExample) |
| CO (1) | CO7141435A2 (enExample) |
| CR (1) | CR20140545A (enExample) |
| EA (1) | EA025884B1 (enExample) |
| IL (1) | IL236808B (enExample) |
| MA (1) | MA37791B1 (enExample) |
| MX (1) | MX362184B (enExample) |
| MY (1) | MY185216A (enExample) |
| NZ (1) | NZ703192A (enExample) |
| PE (1) | PE20150341A1 (enExample) |
| PH (1) | PH12015500059B1 (enExample) |
| SG (1) | SG11201408529VA (enExample) |
| TW (1) | TWI506027B (enExample) |
| UA (1) | UA113013C2 (enExample) |
| WO (1) | WO2014023674A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2673489C2 (ru) * | 2013-09-12 | 2018-11-27 | Ф. Хоффманн-Ля Рош Аг | Производные индолкарбоксамида |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2913335T3 (es) * | 2013-02-18 | 2022-06-01 | Labrador Diagnostics Llc | Análisis de imagen y medición de muestras biológicas |
| MX2015013915A (es) * | 2013-04-02 | 2015-12-11 | Hoffmann La Roche | Piperazino[1,2-a]indol-1-onas y [1,4]diazepino[1,2-a]indol-1-ona. |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002072584A2 (en) * | 2001-03-13 | 2002-09-19 | F. Hoffmann-La Roche Ag | Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders |
| WO2007065820A1 (en) * | 2005-12-09 | 2007-06-14 | F. Hoffmann-La Roche Ag | Tricyclic amide derivatives useful for treating obesity |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1965981C3 (de) * | 1968-02-13 | 1978-08-31 | Sumitomo Chemical Co., Ltd., Osaka (Japan) | 9-Phenyl-lO-oxopiperazino [l,2-a]-indole und Verfahren zu ihrer Herstellung |
| GB0202015D0 (en) * | 2002-01-29 | 2002-03-13 | Hoffmann La Roche | Piperazine Derivatives |
| WO2008046072A2 (en) | 2006-10-13 | 2008-04-17 | The Board Of Regents Of The University Of Texas System | Chemical inducers of neurogenesis |
| MX2009004898A (es) * | 2006-11-09 | 2009-05-19 | Hoffmann La Roche | Derivados de indol y de benzofurano-2-carboxamida. |
| CA2804161A1 (en) | 2010-07-07 | 2012-01-12 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
| MX2015013915A (es) * | 2013-04-02 | 2015-12-11 | Hoffmann La Roche | Piperazino[1,2-a]indol-1-onas y [1,4]diazepino[1,2-a]indol-1-ona. |
-
2013
- 2013-08-05 MY MYPI2014003519A patent/MY185216A/en unknown
- 2013-08-05 JP JP2015525846A patent/JP5974177B2/ja not_active Expired - Fee Related
- 2013-08-05 WO PCT/EP2013/066344 patent/WO2014023674A1/en not_active Ceased
- 2013-08-05 PE PE2015000024A patent/PE20150341A1/es active IP Right Grant
- 2013-08-05 BR BR112015000313A patent/BR112015000313A2/pt not_active Application Discontinuation
- 2013-08-05 SG SG11201408529VA patent/SG11201408529VA/en unknown
- 2013-08-05 KR KR1020157003112A patent/KR101716062B1/ko not_active Expired - Fee Related
- 2013-08-05 UA UAA201501071A patent/UA113013C2/uk unknown
- 2013-08-05 AR ARP130102771A patent/AR092041A1/es unknown
- 2013-08-05 TW TW102128001A patent/TWI506027B/zh not_active IP Right Cessation
- 2013-08-05 EP EP13745648.9A patent/EP2880036B1/en active Active
- 2013-08-05 MX MX2015001318A patent/MX362184B/es active IP Right Grant
- 2013-08-05 CA CA2880682A patent/CA2880682A1/en not_active Abandoned
- 2013-08-05 AU AU2013301577A patent/AU2013301577B2/en not_active Ceased
- 2013-08-05 NZ NZ703192A patent/NZ703192A/en not_active IP Right Cessation
- 2013-08-05 CN CN201380041546.5A patent/CN104540829B/zh not_active Expired - Fee Related
- 2013-08-05 EA EA201590125A patent/EA025884B1/ru not_active IP Right Cessation
-
2014
- 2014-11-27 CR CR20140545A patent/CR20140545A/es unknown
- 2014-11-28 CO CO14262433A patent/CO7141435A2/es unknown
-
2015
- 2015-01-09 PH PH12015500059A patent/PH12015500059B1/en unknown
- 2015-01-19 IL IL236808A patent/IL236808B/en not_active IP Right Cessation
- 2015-01-20 MA MA37791A patent/MA37791B1/fr unknown
- 2015-01-21 CL CL2015000143A patent/CL2015000143A1/es unknown
- 2015-02-04 US US14/614,232 patent/US9284321B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002072584A2 (en) * | 2001-03-13 | 2002-09-19 | F. Hoffmann-La Roche Ag | Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders |
| WO2007065820A1 (en) * | 2005-12-09 | 2007-06-14 | F. Hoffmann-La Roche Ag | Tricyclic amide derivatives useful for treating obesity |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2673489C2 (ru) * | 2013-09-12 | 2018-11-27 | Ф. Хоффманн-Ля Рош Аг | Производные индолкарбоксамида |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102509720B1 (ko) | 치환된 크로만 및 이의 사용 방법 | |
| TWI572607B (zh) | 溴區域抑制劑及其用途 | |
| TWI829676B (zh) | 噁二唑暫時受體電位通道抑制劑 | |
| EP2240483B1 (en) | Pyrimidyl cyclopentanes as akt protein kinase inhibitors | |
| KR101829940B1 (ko) | 프탈라지논 케톤 유도체, 이의 제조방법, 및 이의 약학적 용도 | |
| JP6967522B2 (ja) | Betブロモドメイン阻害剤としての融合1,4−オキサゼピンおよび関連類似体 | |
| JP2016519660A (ja) | ブロモドメイン阻害剤としてのオキサゾロ[5,4−c]キノリン−2−オン化合物 | |
| EA004989B1 (ru) | Трициклические ингибиторы поли(adp-рибозо)полимераз | |
| JP2004530692A (ja) | カスパーゼの活性化因子およびアポトーシスの誘導因子としての置換された4h−クロメンおよび類似体、並びにその使用方法 | |
| CN110872296A (zh) | 一种二氢异吲哚-1H-吡唑并[3,4-d]嘧啶酮化合物、其制备方法和应用 | |
| CN112823157A (zh) | 螺色满衍生物 | |
| WO2016196071A1 (en) | 6-alkyl dihydropyrazolopyrimidinone compounds as pde2 inhibitors | |
| EA025884B1 (ru) | ПИПЕРАЗИНО[1,2-a]ИНДОЛ-1-ОНЫ И [1,4]ДИАЗЕПИНО[1,2-a]ИНДОЛ-1-ОН | |
| CN102770182B (zh) | 被取代的异喹啉酮类和喹唑酮类 | |
| JP2018527340A (ja) | アリール置換ジヒドロキノリノン、その調製及び医薬品としてのその使用 | |
| EP4596554A1 (en) | Aza-fused ring compound, preparation method therefor, and use thereof in medicine | |
| JP2025526508A (ja) | 三環式アリール誘導体、ならびにその組成物および方法 | |
| KR101767329B1 (ko) | 피페라지노[1,2-a]인돌-1-온 및 [1,4]다이아제피노[1,2-a]인돌-1-온 | |
| CN106496249B (zh) | 噁唑并吲哚类衍生物、其制备方法及其在医药上的应用 | |
| CN113754685B (zh) | 二氢硫代色烯并吡唑类衍生物、其制备方法及其在医药上的应用 | |
| EA030371B1 (ru) | Дигидрооксазинобензодиазепиновые соединения, способ их получения и содержащие их фармацевтические композиции | |
| CN119591605A (zh) | 稠合三环类pkmyt1抑制剂 | |
| TW202241910A (zh) | 苯並嘧啶三環衍生物及製備方法和應用 | |
| HK1206355B (en) | Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-1-one |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM |
|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |